CINXE.COM

<!DOCTYPE html><html lang="en"><head><link rel="stylesheet" data-href="https://fonts.googleapis.com/css?family=Trade+Gothic+Lt+Bold%7COpen+Sans%7CTrade+Gothic+Lt&display=swap" data-optimized-fonts="true"/><title>Pharmafocus - Magazine Issues</title><link rel="icon" href="https://cdn.magloft.com/pwa-664/pwa/logo/8eb186e1-b2cb-4384-a0b7-515f62171b22.png"/><link rel="shortcut icon" type="image/x-icon" href="https://cdn.magloft.com/pwa-664/pwa/logo/8eb186e1-b2cb-4384-a0b7-515f62171b22.png?optimizer=image&format=webp&width=180&aspectRatio=1"/><link rel="apple-touch-icon" sizes="180x180" href="https://cdn.magloft.com/pwa-664/pwa/logo/8eb186e1-b2cb-4384-a0b7-515f62171b22.png?optimizer=image&format=webp&width=180&aspectRatio=1"/><meta name="application-name" content="Pharmafocus - Magazine Issues"/><meta name="apple-mobile-web-app-capable" content="yes"/><meta name="apple-mobile-web-app-status-bar-style" content="default"/><meta name="apple-mobile-web-app-title" content="Pharmafocus - Magazine Issues"/><meta name="format-detection" content="telephone=no"/><meta name="mobile-web-app-capable" content="yes"/><meta name="msapplication-TileColor" content="#1976D2"/><meta name="msapplication-tap-highlight" content="no"/><link rel="manifest" href="/manifest.json"/><meta name="twitter:url" content="https://www.pharmafocus.com"/><meta name="theme-color" content="#1976D2"/><meta name="viewport" content="width=device-width, initial-scale=1"/><meta charSet="utf-8"/><meta itemProp="name" content="Pharmafocus - Magazine Issues"/><meta itemProp="description" content="Pharmafocus - Magazine Issues"/><meta name="description" content="Pharmafocus - Magazine Issues"/><meta itemProp="image" content="https://cdn.magloft.com/pwa-664/seo/image/b1c374f3-b368-4654-bf00-3b5ed81fe6c2.png"/><meta property="og:description" content="Pharmafocus - Magazine Issues"/><meta property="og:title" content="Pharmafocus - Magazine Issues"/><meta property="og:site_name" content="Pharmafocus - Magazine Issues"/><meta property="og:image" content="https://cdn.magloft.com/pwa-664/seo/image/b1c374f3-b368-4654-bf00-3b5ed81fe6c2.png"/><meta property="og:type" content="website"/><meta name="twitter:card" content="summary_large_image"/><meta name="twitter:title" content="Pharmafocus - Magazine Issues"/><meta name="twitter:description" content="Pharmafocus - Magazine Issues"/><meta name="twitter:image" content="https://cdn.magloft.com/pwa-664/seo/image/b1c374f3-b368-4654-bf00-3b5ed81fe6c2.png"/><meta name="twitter:site" content="@Pharmafocus"/><meta name="twitter:creator" content="@Pharmafocus"/><style>html{--heading-font: "Trade Gothic Lt Bold";--body-font: "Open Sans";--ui-font: "Trade Gothic Lt Bold";--top-menu-title-font: "Trade Gothic Lt Bold";--top-menu-subtitle-font: "Trade Gothic Lt";--top-menu-items-font: "Trade Gothic Lt";--footer-menu-title-font: "Trade Gothic Lt Bold";--footer-menu-items-font: "Trade Gothic Lt Bold";--background-color: #FFFFFF;--background-color-dark: #808080;--primary-color: #1976D2;--primary-color-dark: #0C3B69;--secondary-color: #795FF4;--secondary-color-dark: #250B9F;--accent-color: #D76FD6;--accent-color-dark: #80237F;--info-color: #41638C;--info-color-dark: #213246;--warning-color: #EF9338;--warning-color-dark: #89490B;--success-color: #20AD27;--success-color-dark: #105714;--danger-color: #DF4241;--danger-color-dark: #7B1515;--top-menu-background-color: #EE1C25;--top-menu-background-color-dark: #7C090E;--footer-menu-background-color: #DF1111;--footer-menu-background-color-dark: #6F0808;--navbar-height: 64px; }</style><link rel="stylesheet" href="https://cdn.magloft.com/reader/fonts/trade-gothic-lt.css"/><link rel="stylesheet" href="https://cdn.magloft.com/reader/fonts/trade-gothic-lt-bold.css"/><script type="text/javascript" src="https://cdn.jsdelivr.net/npm/cookie-bar/cookiebar-latest.min.js?customize=1&always=1&showNoConsent=1"></script><meta name="google-site-verification" content="kuOvGxaH_NjG3aS7GSmbjjV-OjdOAWyiM3gEPGESeHQ"/><style> #billboard-banner { text-align:center;} #billboard-banner img {width:100%; max-width:970px; height:auto; position:relative; top:70px;} .Layout_spacer__qTBD3 {margin-top:70px;} </style><meta name="next-head-count" content="39"/><link rel="preconnect" href="https://fonts.googleapis.com"/><link rel="preconnect" href="https://fonts.gstatic.com"/><link rel="preload" href="/_next/static/css/229efe2956472d85.css" as="style"/><link rel="stylesheet" href="/_next/static/css/229efe2956472d85.css" data-n-g=""/><link rel="preload" href="/_next/static/css/5dcc38b90034d324.css" as="style"/><link rel="stylesheet" href="/_next/static/css/5dcc38b90034d324.css" data-n-p=""/><noscript data-n-css=""></noscript><script defer="" nomodule="" src="/_next/static/chunks/polyfills-c67a75d1b6f99dc8.js"></script><script defer="" src="https://fonts.googleapis.com/css?family=Open+Sans&display=swap" data-nscript="beforeInteractive"></script><script src="/_next/static/chunks/webpack-b653c683a51d8b57.js" defer=""></script><script src="/_next/static/chunks/framework-73b8966a3c579ab0.js" defer=""></script><script src="/_next/static/chunks/main-34cb81d5753e1fc4.js" defer=""></script><script src="/_next/static/chunks/pages/_app-9cc101b503fd5646.js" defer=""></script><script src="/_next/static/chunks/655-d6e1933688b2da2a.js" defer=""></script><script src="/_next/static/chunks/pages/domains/%5Bdomain%5D/categories/%5Bslug%5D-06ee3613a207102c.js" defer=""></script><script src="/_next/static/1bBCYhXOG7wsYuaBifvjK/_buildManifest.js" defer=""></script><script src="/_next/static/1bBCYhXOG7wsYuaBifvjK/_ssgManifest.js" defer=""></script><style data-styled="" data-styled-version="5.3.9"></style><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Trade+Gothic+Lt+Bold%7COpen+Sans%7CTrade+Gothic+Lt&display=swap"/></head><body><div id="__next"><div class="Layout_container__gktH6"><div class="Layout_navbar-container__gCfDZ" style="height:64px"><nav class="_wrapper_jbnbd_1"><div class="_container_jbnbd_15"><a class="_navbar-brand_jbnbd_29" aria-label="Pharmafocus" href="/"><div class="_navbar-image_jbnbd_40"><img alt="Logo" loading="lazy" decoding="async" data-nimg="fill" class="_image_jbnbd_43" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent" sizes="100vw" srcSet="https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 54w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 70w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 82w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 96w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 110w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 128w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 138w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 192w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 200w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 252w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 260w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 298w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 378w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 384w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 520w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 640w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 756w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 828w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 1080w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 1200w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 1920w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 2048w" src="https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png"/></div><div class="_navbar-title_jbnbd_58 _navbar-title-hide_jbnbd_101"></div></a><div id="navbar-children-container" class="_navbar-children_jbnbd_116"><div class="_menu_1jhrl_1"><div class="_menu-wrapper_1jhrl_22"><div class="_menu-items_1jhrl_38"><a class="_menu-item_1jhrl_38" href="/"><div class="_menu-home_1lm7t_255 _menu-item-icon_1jhrl_97 _icon_1lm7t_1 icon"></div><div class="_menu-item-title_1jhrl_88">Home</div><div class="_indicator_1jhrl_63"></div></a><a class="_menu-item_1jhrl_38" href="/articles"><div class="_menu-articles_1lm7t_259 _menu-item-icon_1jhrl_97 _icon_1lm7t_1 icon"></div><div class="_menu-item-title_1jhrl_88">Articles</div><div class="_indicator_1jhrl_63"></div></a><a class="_menu-item_1jhrl_38 _active_1jhrl_70" href="/collections"><div class="_menu-issues_1lm7t_263 _menu-item-icon_1jhrl_97 _icon_1lm7t_1 icon"></div><div class="_menu-item-title_1jhrl_88">Magazines</div><div class="_indicator_1jhrl_63 _active_1jhrl_70"></div></a><a class="_menu-item_1jhrl_38" href="/account/login"><div class="_menu-account_1lm7t_411 _menu-item-icon_1jhrl_97 _icon_1lm7t_1 icon"></div><div class="_menu-item-title_1jhrl_88">Log in</div><div class="_indicator_1jhrl_63"></div></a></div></div></div></div><div id="navbar-suffix" class="_navbar-suffix_jbnbd_108"><div class="Layout_menu-actions__vsDbI"><div class="Layout_install-button__FBfSr"><div class="Tooltip_tooltip__98Sw9"></div><button class="_button_19h3g_1 _text_19h3g_12 _medium_19h3g_38 _secondary_19h3g_22" type="button" style="color:var(--top-menu-item-icon-color, var(--background-color))" role="button" aria-label="Search" aria-labelledby="labeldiv" title="Search"><div class="_action-search_1lm7t_15 _icon-button_19h3g_19 _icon_1lm7t_1 icon" style="background-color:var(--top-menu-item-icon-color, var(--background-color))"></div></button></div></div></div></div></nav></div><div class="Layout_main__evUHx"><div class="Layout_spacer__qTBD3" style="height:64px"></div><div class="_slug__wrapper__ruU0S"><div class="_slug__category-header__7cydo"><img alt="Issue Cover" loading="lazy" width="128" height="128" decoding="async" data-nimg="1" class="_slug__category-image___YpSr" style="color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url("data:image/svg+xml;charset=utf-8,%3Csvg xmlns='http%3A//www.w3.org/2000/svg' viewBox='0 0 128 128'%3E%3Cfilter id='b' color-interpolation-filters='sRGB'%3E%3CfeGaussianBlur stdDeviation='20'/%3E%3C/filter%3E%3Cimage preserveAspectRatio='none' filter='url(%23b)' x='0' y='0' height='100%25' width='100%25' href='data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw=='/%3E%3C/svg%3E")" srcSet="https://media.magloft.app/pwa-664/category/image/e94277d7-5b82-4bb7-9606-4583408ba608.jpg?optimizer=image&format=webp&width=128&aspectRatio=1 1x, https://media.magloft.app/pwa-664/category/image/e94277d7-5b82-4bb7-9606-4583408ba608.jpg?optimizer=image&format=webp&width=256&aspectRatio=1 2x" src="https://media.magloft.app/pwa-664/category/image/e94277d7-5b82-4bb7-9606-4583408ba608.jpg?optimizer=image&format=webp&width=256&aspectRatio=1"/><h2>Approvals</h2><p>The latest approvals from the global pharmaceutical industry.</p></div><div style="height:auto" class="BlockHeader_block-header__JmokO"><div class="BlockHeader_container-title__l5lHB"><h2 style="border-bottom-color:#444444">Collections</h2></div></div><div class="IssueList_wrapper__cNptl"><div class="infinite-scroll-component__outerdiv"><div class="infinite-scroll-component " style="height:auto;overflow:visible;-webkit-overflow-scrolling:touch"><div class="IssueList_container__tG81k"><div class="_card_1s1n3_1 card raised interactive"><div class="_card-body_1s1n3_12 card-body"><div class="_issue-cover_1s1n3_17"><a href="/collections/pharmafocus-november-2024"><img alt="issue-item" loading="lazy" width="768" height="1024" decoding="async" data-nimg="1" style="color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url("data:image/svg+xml;charset=utf-8,%3Csvg xmlns='http%3A//www.w3.org/2000/svg' viewBox='0 0 768 1024'%3E%3Cfilter id='b' color-interpolation-filters='sRGB'%3E%3CfeGaussianBlur stdDeviation='20'/%3E%3C/filter%3E%3Cimage preserveAspectRatio='none' filter='url(%23b)' x='0' y='0' height='100%25' width='100%25' href='data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw=='/%3E%3C/svg%3E")" sizes="(min-width: 796px) 200px, (min-width: 601px) 252px, 192px" srcSet="https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&format=webp&aspectRatio=0.75&width=16 16w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&format=webp&aspectRatio=0.75&width=32 32w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&format=webp&aspectRatio=0.75&width=48 48w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&format=webp&aspectRatio=0.75&width=54 54w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&format=webp&aspectRatio=0.75&width=64 64w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&format=webp&aspectRatio=0.75&width=70 70w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&format=webp&aspectRatio=0.75&width=82 82w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&format=webp&aspectRatio=0.75&width=96 96w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&format=webp&aspectRatio=0.75&width=96 96w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&format=webp&aspectRatio=0.75&width=110 110w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&format=webp&aspectRatio=0.75&width=128 128w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&format=webp&aspectRatio=0.75&width=128 128w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&format=webp&aspectRatio=0.75&width=138 138w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&format=webp&aspectRatio=0.75&width=192 192w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&format=webp&aspectRatio=0.75&width=200 200w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&format=webp&aspectRatio=0.75&width=252 252w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&format=webp&aspectRatio=0.75&width=256 256w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&format=webp&aspectRatio=0.75&width=260 260w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&format=webp&aspectRatio=0.75&width=298 298w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&format=webp&aspectRatio=0.75&width=378 378w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&format=webp&aspectRatio=0.75&width=384 384w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&format=webp&aspectRatio=0.75&width=384 384w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&format=webp&aspectRatio=0.75&width=520 520w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&format=webp&aspectRatio=0.75&width=640 640w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&format=webp&aspectRatio=0.75&width=756 756w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&format=webp&aspectRatio=0.75&width=828 828w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&format=webp&aspectRatio=0.75&width=1080 1080w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&format=webp&aspectRatio=0.75&width=1200 1200w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&format=webp&aspectRatio=0.75&width=1920 1920w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&format=webp&aspectRatio=0.75&width=2048 2048w" src="https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&format=webp&aspectRatio=0.75&width=2048"/></a></div><div class="_issue-detail_1s1n3_27"><div class="_issue-detail-header_1s1n3_33"><div class="_card-date_1s1n3_39"><a href="/collections/pharmafocus-november-2024"><span>UK News </span>15 November 2024</a></div></div><div class="_issue-detail-content_1s1n3_52"><div><a href="/collections/pharmafocus-november-2024"><p class="_card-title_1s1n3_56">Pharmafocus November 2024</p><p class="_description_1s1n3_67">Welcome to Pharmafocus November 2024!</p></a></div></div><div class="_issue-action-wrapper_1s1n3_79"><a href="/collections/pharmafocus-november-2024"><button class="_button_19h3g_1 _text_19h3g_12 _medium_19h3g_38 _primary_19h3g_15" type="button" role="button" aria-label="Pending" aria-labelledby="labeldiv">...</button></a></div></div></div></div><div class="_card_1s1n3_1 card raised interactive"><div class="_card-body_1s1n3_12 card-body"><div class="_issue-cover_1s1n3_17"><a href="/collections/pharmafocus-october-2024"><img alt="issue-item" loading="lazy" width="768" height="1024" decoding="async" data-nimg="1" style="color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url("data:image/svg+xml;charset=utf-8,%3Csvg xmlns='http%3A//www.w3.org/2000/svg' viewBox='0 0 768 1024'%3E%3Cfilter id='b' color-interpolation-filters='sRGB'%3E%3CfeGaussianBlur stdDeviation='20'/%3E%3C/filter%3E%3Cimage preserveAspectRatio='none' filter='url(%23b)' x='0' y='0' height='100%25' width='100%25' href='data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw=='/%3E%3C/svg%3E")" sizes="(min-width: 796px) 200px, (min-width: 601px) 252px, 192px" srcSet="https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&format=webp&aspectRatio=0.75&width=16 16w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&format=webp&aspectRatio=0.75&width=32 32w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&format=webp&aspectRatio=0.75&width=48 48w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&format=webp&aspectRatio=0.75&width=54 54w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&format=webp&aspectRatio=0.75&width=64 64w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&format=webp&aspectRatio=0.75&width=70 70w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&format=webp&aspectRatio=0.75&width=82 82w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&format=webp&aspectRatio=0.75&width=96 96w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&format=webp&aspectRatio=0.75&width=96 96w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&format=webp&aspectRatio=0.75&width=110 110w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&format=webp&aspectRatio=0.75&width=128 128w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&format=webp&aspectRatio=0.75&width=128 128w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&format=webp&aspectRatio=0.75&width=138 138w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&format=webp&aspectRatio=0.75&width=192 192w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&format=webp&aspectRatio=0.75&width=200 200w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&format=webp&aspectRatio=0.75&width=252 252w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&format=webp&aspectRatio=0.75&width=256 256w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&format=webp&aspectRatio=0.75&width=260 260w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&format=webp&aspectRatio=0.75&width=298 298w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&format=webp&aspectRatio=0.75&width=378 378w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&format=webp&aspectRatio=0.75&width=384 384w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&format=webp&aspectRatio=0.75&width=384 384w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&format=webp&aspectRatio=0.75&width=520 520w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&format=webp&aspectRatio=0.75&width=640 640w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&format=webp&aspectRatio=0.75&width=756 756w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&format=webp&aspectRatio=0.75&width=828 828w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&format=webp&aspectRatio=0.75&width=1080 1080w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&format=webp&aspectRatio=0.75&width=1200 1200w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&format=webp&aspectRatio=0.75&width=1920 1920w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&format=webp&aspectRatio=0.75&width=2048 2048w" src="https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&format=webp&aspectRatio=0.75&width=2048"/></a></div><div class="_issue-detail_1s1n3_27"><div class="_issue-detail-header_1s1n3_33"><div class="_card-date_1s1n3_39"><a href="/collections/pharmafocus-october-2024"><span>UK News </span>10 October 2024</a></div></div><div class="_issue-detail-content_1s1n3_52"><div><a href="/collections/pharmafocus-october-2024"><p class="_card-title_1s1n3_56">Pharmafocus October 2024</p><p class="_description_1s1n3_67">Welcome to the October 2024 edition of Pharmafocus!</p></a></div></div><div class="_issue-action-wrapper_1s1n3_79"><a href="/collections/pharmafocus-october-2024"><button class="_button_19h3g_1 _text_19h3g_12 _medium_19h3g_38 _primary_19h3g_15" type="button" role="button" aria-label="Pending" aria-labelledby="labeldiv">...</button></a></div></div></div></div><div class="_card_1s1n3_1 card raised interactive"><div class="_card-body_1s1n3_12 card-body"><div class="_issue-cover_1s1n3_17"><a href="/collections/pharmafocus-september-2024"><img alt="issue-item" loading="lazy" width="768" height="1024" decoding="async" data-nimg="1" style="color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url("data:image/svg+xml;charset=utf-8,%3Csvg xmlns='http%3A//www.w3.org/2000/svg' viewBox='0 0 768 1024'%3E%3Cfilter id='b' color-interpolation-filters='sRGB'%3E%3CfeGaussianBlur stdDeviation='20'/%3E%3C/filter%3E%3Cimage preserveAspectRatio='none' filter='url(%23b)' x='0' y='0' height='100%25' width='100%25' href='data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw=='/%3E%3C/svg%3E")" sizes="(min-width: 796px) 200px, (min-width: 601px) 252px, 192px" srcSet="https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&format=webp&aspectRatio=0.75&width=16 16w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&format=webp&aspectRatio=0.75&width=32 32w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&format=webp&aspectRatio=0.75&width=48 48w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&format=webp&aspectRatio=0.75&width=54 54w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&format=webp&aspectRatio=0.75&width=64 64w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&format=webp&aspectRatio=0.75&width=70 70w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&format=webp&aspectRatio=0.75&width=82 82w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&format=webp&aspectRatio=0.75&width=96 96w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&format=webp&aspectRatio=0.75&width=96 96w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&format=webp&aspectRatio=0.75&width=110 110w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&format=webp&aspectRatio=0.75&width=128 128w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&format=webp&aspectRatio=0.75&width=128 128w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&format=webp&aspectRatio=0.75&width=138 138w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&format=webp&aspectRatio=0.75&width=192 192w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&format=webp&aspectRatio=0.75&width=200 200w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&format=webp&aspectRatio=0.75&width=252 252w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&format=webp&aspectRatio=0.75&width=256 256w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&format=webp&aspectRatio=0.75&width=260 260w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&format=webp&aspectRatio=0.75&width=298 298w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&format=webp&aspectRatio=0.75&width=378 378w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&format=webp&aspectRatio=0.75&width=384 384w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&format=webp&aspectRatio=0.75&width=384 384w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&format=webp&aspectRatio=0.75&width=520 520w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&format=webp&aspectRatio=0.75&width=640 640w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&format=webp&aspectRatio=0.75&width=756 756w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&format=webp&aspectRatio=0.75&width=828 828w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&format=webp&aspectRatio=0.75&width=1080 1080w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&format=webp&aspectRatio=0.75&width=1200 1200w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&format=webp&aspectRatio=0.75&width=1920 1920w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&format=webp&aspectRatio=0.75&width=2048 2048w" src="https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&format=webp&aspectRatio=0.75&width=2048"/></a></div><div class="_issue-detail_1s1n3_27"><div class="_issue-detail-header_1s1n3_33"><div class="_card-date_1s1n3_39"><a href="/collections/pharmafocus-september-2024"><span>UK News </span>5 September 2024</a></div></div><div class="_issue-detail-content_1s1n3_52"><div><a href="/collections/pharmafocus-september-2024"><p class="_card-title_1s1n3_56">Pharmafocus September 2024</p><p class="_description_1s1n3_67">Welcome to the September 2024 issue of Pharmafocus! This issue covers the latest news including new FDA approval for primary biliary cholangitis, NICE recommendations for skyrizi (risankizumab), CHMP opinion on Merck’s KEYTRUDA, as well as articles on precision medicine and oral peptides PLUS what to look out for at this year's CPHI in Milan! </p></a></div></div><div class="_issue-action-wrapper_1s1n3_79"><a href="/collections/pharmafocus-september-2024"><button class="_button_19h3g_1 _text_19h3g_12 _medium_19h3g_38 _primary_19h3g_15" type="button" role="button" aria-label="Pending" aria-labelledby="labeldiv">...</button></a></div></div></div></div></div></div></div></div><div style="height:auto" class="BlockHeader_block-header__JmokO"><div class="BlockHeader_container-title__l5lHB"><h2 style="border-bottom-color:#444444">Articles</h2></div></div><div class="ArticleList_wrapper__T0ntw"><div class="infinite-scroll-component__outerdiv"><div class="infinite-scroll-component " style="height:auto;overflow:visible;-webkit-overflow-scrolling:touch"><div class="ArticleList_container__ln6vK"><a class="_card_n1ew6_1" href="/articles/nice-gives-positive-recommendation-for-santen-s-roclanda-e19d"><div class="_card-header_n1ew6_50"><img alt="article-item" loading="lazy" width="86" height="64.5" decoding="async" data-nimg="1" style="color:transparent;width:100%;height:auto;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url("data:image/svg+xml;charset=utf-8,%3Csvg xmlns='http%3A//www.w3.org/2000/svg' viewBox='0 0 86 64.5'%3E%3Cfilter id='b' color-interpolation-filters='sRGB'%3E%3CfeGaussianBlur stdDeviation='20'/%3E%3C/filter%3E%3Cimage preserveAspectRatio='none' filter='url(%23b)' x='0' y='0' height='100%25' width='100%25' href='data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw=='/%3E%3C/svg%3E")" sizes="(min-width: 874px) 38vw, (min-width: 720px) 44vw, (min-width: 601px) 19vw, 10vw" srcSet="https://media.magloft.app/pdf-import/1144/images/pages/pg-012.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=16 16w, https://media.magloft.app/pdf-import/1144/images/pages/pg-012.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=32 32w, https://media.magloft.app/pdf-import/1144/images/pages/pg-012.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=48 48w, https://media.magloft.app/pdf-import/1144/images/pages/pg-012.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=54 54w, https://media.magloft.app/pdf-import/1144/images/pages/pg-012.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=64 64w, https://media.magloft.app/pdf-import/1144/images/pages/pg-012.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=70 70w, https://media.magloft.app/pdf-import/1144/images/pages/pg-012.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=82 82w, https://media.magloft.app/pdf-import/1144/images/pages/pg-012.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=96 96w, https://media.magloft.app/pdf-import/1144/images/pages/pg-012.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=96 96w, https://media.magloft.app/pdf-import/1144/images/pages/pg-012.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=110 110w, https://media.magloft.app/pdf-import/1144/images/pages/pg-012.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=128 128w, https://media.magloft.app/pdf-import/1144/images/pages/pg-012.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=128 128w, https://media.magloft.app/pdf-import/1144/images/pages/pg-012.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=138 138w, https://media.magloft.app/pdf-import/1144/images/pages/pg-012.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=192 192w, https://media.magloft.app/pdf-import/1144/images/pages/pg-012.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=200 200w, https://media.magloft.app/pdf-import/1144/images/pages/pg-012.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=252 252w, https://media.magloft.app/pdf-import/1144/images/pages/pg-012.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=256 256w, https://media.magloft.app/pdf-import/1144/images/pages/pg-012.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=260 260w, https://media.magloft.app/pdf-import/1144/images/pages/pg-012.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=298 298w, https://media.magloft.app/pdf-import/1144/images/pages/pg-012.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=378 378w, https://media.magloft.app/pdf-import/1144/images/pages/pg-012.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=384 384w, https://media.magloft.app/pdf-import/1144/images/pages/pg-012.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=384 384w, https://media.magloft.app/pdf-import/1144/images/pages/pg-012.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=520 520w, https://media.magloft.app/pdf-import/1144/images/pages/pg-012.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=640 640w, https://media.magloft.app/pdf-import/1144/images/pages/pg-012.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=756 756w, https://media.magloft.app/pdf-import/1144/images/pages/pg-012.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=828 828w, https://media.magloft.app/pdf-import/1144/images/pages/pg-012.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=1080 1080w, https://media.magloft.app/pdf-import/1144/images/pages/pg-012.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=1200 1200w, https://media.magloft.app/pdf-import/1144/images/pages/pg-012.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=1920 1920w, https://media.magloft.app/pdf-import/1144/images/pages/pg-012.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=2048 2048w" src="https://media.magloft.app/pdf-import/1144/images/pages/pg-012.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=2048"/></div><div class="_card-body_n1ew6_86"><span class="_card-title_n1ew6_103">NICE gives positive recommendation for Santen’s Roclanda</span><p class="">The National Institute for Health and Care Excellence (NICE) has given a positive recommendation for Santen’s Roclanda (netarsudil 0.02% and latanoprost 0.005%) as an option for patients suffering from primary open-angle glaucoma (poag) or ocular hypertension.</p><div class="_card-date_n1ew6_142">15 November 2024<span class="_category-chip_n1ew6_155" style="background-color:#444444">Approvals</span></div></div><div class="_card-footer_n1ew6_162"><button class="_button_19h3g_1 _text_19h3g_12 _medium_19h3g_38 _secondary_19h3g_22" type="button">Read More</button></div></a><a class="_card_n1ew6_1" href="/articles/chmp-adopts-positive-opinion-for-new-breast-cancer-drug-kisqual-db01"><div class="_card-header_n1ew6_50"><img alt="article-item" loading="lazy" width="86" height="64.5" decoding="async" data-nimg="1" style="color:transparent;width:100%;height:auto;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url("data:image/svg+xml;charset=utf-8,%3Csvg xmlns='http%3A//www.w3.org/2000/svg' viewBox='0 0 86 64.5'%3E%3Cfilter id='b' color-interpolation-filters='sRGB'%3E%3CfeGaussianBlur stdDeviation='20'/%3E%3C/filter%3E%3Cimage preserveAspectRatio='none' filter='url(%23b)' x='0' y='0' height='100%25' width='100%25' href='data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw=='/%3E%3C/svg%3E")" sizes="(min-width: 874px) 38vw, (min-width: 720px) 44vw, (min-width: 601px) 19vw, 10vw" srcSet="https://media.magloft.app/pdf-import/1144/images/img_12-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=16 16w, https://media.magloft.app/pdf-import/1144/images/img_12-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=32 32w, https://media.magloft.app/pdf-import/1144/images/img_12-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=48 48w, https://media.magloft.app/pdf-import/1144/images/img_12-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=54 54w, https://media.magloft.app/pdf-import/1144/images/img_12-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=64 64w, https://media.magloft.app/pdf-import/1144/images/img_12-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=70 70w, https://media.magloft.app/pdf-import/1144/images/img_12-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=82 82w, https://media.magloft.app/pdf-import/1144/images/img_12-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=96 96w, https://media.magloft.app/pdf-import/1144/images/img_12-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=96 96w, https://media.magloft.app/pdf-import/1144/images/img_12-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=110 110w, https://media.magloft.app/pdf-import/1144/images/img_12-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=128 128w, https://media.magloft.app/pdf-import/1144/images/img_12-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=128 128w, https://media.magloft.app/pdf-import/1144/images/img_12-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=138 138w, https://media.magloft.app/pdf-import/1144/images/img_12-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=192 192w, https://media.magloft.app/pdf-import/1144/images/img_12-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=200 200w, https://media.magloft.app/pdf-import/1144/images/img_12-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=252 252w, https://media.magloft.app/pdf-import/1144/images/img_12-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=256 256w, https://media.magloft.app/pdf-import/1144/images/img_12-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=260 260w, https://media.magloft.app/pdf-import/1144/images/img_12-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=298 298w, https://media.magloft.app/pdf-import/1144/images/img_12-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=378 378w, https://media.magloft.app/pdf-import/1144/images/img_12-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=384 384w, https://media.magloft.app/pdf-import/1144/images/img_12-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=384 384w, https://media.magloft.app/pdf-import/1144/images/img_12-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=520 520w, https://media.magloft.app/pdf-import/1144/images/img_12-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=640 640w, https://media.magloft.app/pdf-import/1144/images/img_12-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=756 756w, https://media.magloft.app/pdf-import/1144/images/img_12-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=828 828w, https://media.magloft.app/pdf-import/1144/images/img_12-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=1080 1080w, https://media.magloft.app/pdf-import/1144/images/img_12-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=1200 1200w, https://media.magloft.app/pdf-import/1144/images/img_12-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=1920 1920w, https://media.magloft.app/pdf-import/1144/images/img_12-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=2048 2048w" src="https://media.magloft.app/pdf-import/1144/images/img_12-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=2048"/></div><div class="_card-body_n1ew6_86"><span class="_card-title_n1ew6_103">CHMP adopts positive opinion for new breast cancer drug, Kisquali, from Novartis</span><p class="">Last month, the Committee for Medicinal Products for Human Use (CHMP), which is part of the European Medicines Agency (EMA) announced that it has adopted a positive opinion for Novartis’ Kisquali (ribociclib) as an adjuvant in the treatment of adults with hormone receptor-positive/human epidermal growth factor 2negative (hr+/her2-) early breast cancer (ebc).</p><div class="_card-date_n1ew6_142">15 November 2024<span class="_category-chip_n1ew6_155" style="background-color:#444444">Approvals</span></div></div><div class="_card-footer_n1ew6_162"><button class="_button_19h3g_1 _text_19h3g_12 _medium_19h3g_38 _secondary_19h3g_22" type="button">Read More</button></div></a><a class="_card_n1ew6_1" href="/articles/eplontersen-recommended-for-eu-approval-by-chmp-for-treatment-of-aaa6"><div class="_card-header_n1ew6_50"><img alt="article-item" loading="lazy" width="86" height="64.5" decoding="async" data-nimg="1" style="color:transparent;width:100%;height:auto;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url("data:image/svg+xml;charset=utf-8,%3Csvg xmlns='http%3A//www.w3.org/2000/svg' viewBox='0 0 86 64.5'%3E%3Cfilter id='b' color-interpolation-filters='sRGB'%3E%3CfeGaussianBlur stdDeviation='20'/%3E%3C/filter%3E%3Cimage preserveAspectRatio='none' filter='url(%23b)' x='0' y='0' height='100%25' width='100%25' href='data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw=='/%3E%3C/svg%3E")" sizes="(min-width: 874px) 38vw, (min-width: 720px) 44vw, (min-width: 601px) 19vw, 10vw" srcSet="https://media.magloft.app/pdf-import/1144/images/img_13-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=16 16w, https://media.magloft.app/pdf-import/1144/images/img_13-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=32 32w, https://media.magloft.app/pdf-import/1144/images/img_13-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=48 48w, https://media.magloft.app/pdf-import/1144/images/img_13-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=54 54w, https://media.magloft.app/pdf-import/1144/images/img_13-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=64 64w, https://media.magloft.app/pdf-import/1144/images/img_13-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=70 70w, https://media.magloft.app/pdf-import/1144/images/img_13-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=82 82w, https://media.magloft.app/pdf-import/1144/images/img_13-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=96 96w, https://media.magloft.app/pdf-import/1144/images/img_13-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=96 96w, https://media.magloft.app/pdf-import/1144/images/img_13-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=110 110w, https://media.magloft.app/pdf-import/1144/images/img_13-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=128 128w, https://media.magloft.app/pdf-import/1144/images/img_13-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=128 128w, https://media.magloft.app/pdf-import/1144/images/img_13-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=138 138w, https://media.magloft.app/pdf-import/1144/images/img_13-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=192 192w, https://media.magloft.app/pdf-import/1144/images/img_13-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=200 200w, https://media.magloft.app/pdf-import/1144/images/img_13-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=252 252w, https://media.magloft.app/pdf-import/1144/images/img_13-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=256 256w, https://media.magloft.app/pdf-import/1144/images/img_13-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=260 260w, https://media.magloft.app/pdf-import/1144/images/img_13-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=298 298w, https://media.magloft.app/pdf-import/1144/images/img_13-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=378 378w, https://media.magloft.app/pdf-import/1144/images/img_13-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=384 384w, https://media.magloft.app/pdf-import/1144/images/img_13-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=384 384w, https://media.magloft.app/pdf-import/1144/images/img_13-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=520 520w, https://media.magloft.app/pdf-import/1144/images/img_13-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=640 640w, https://media.magloft.app/pdf-import/1144/images/img_13-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=756 756w, https://media.magloft.app/pdf-import/1144/images/img_13-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=828 828w, https://media.magloft.app/pdf-import/1144/images/img_13-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=1080 1080w, https://media.magloft.app/pdf-import/1144/images/img_13-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=1200 1200w, https://media.magloft.app/pdf-import/1144/images/img_13-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=1920 1920w, https://media.magloft.app/pdf-import/1144/images/img_13-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=2048 2048w" src="https://media.magloft.app/pdf-import/1144/images/img_13-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=2048"/></div><div class="_card-body_n1ew6_86"><span class="_card-title_n1ew6_103">Eplontersen recommended for EU approval by CHMP for hereditary transthyretin-mediated amyloidosis</span><p class="">Wainzua (Eplotersen), produced by AstraZeneca and Ionis, has been recommended for approval in the EU by the European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP). The drug will be used as a treatment for hereditary transthyretin-mediated amyloidosis in adult patients who have stage 1 or 2 polyneuropathy (commonly referred to as hattr-pn or attrv-pn).</p><div class="_card-date_n1ew6_142">15 November 2024<span class="_category-chip_n1ew6_155" style="background-color:#444444">Approvals</span></div></div><div class="_card-footer_n1ew6_162"><button class="_button_19h3g_1 _text_19h3g_12 _medium_19h3g_38 _secondary_19h3g_22" type="button">Read More</button></div></a><a class="_card_n1ew6_1" href="/articles/cytex-ortho-receives-fda-greenlight-for-clinical-trials-into-join-f46a"><div class="_card-header_n1ew6_50"><img alt="article-item" loading="lazy" width="86" height="64.5" decoding="async" data-nimg="1" style="color:transparent;width:100%;height:auto;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url("data:image/svg+xml;charset=utf-8,%3Csvg xmlns='http%3A//www.w3.org/2000/svg' viewBox='0 0 86 64.5'%3E%3Cfilter id='b' color-interpolation-filters='sRGB'%3E%3CfeGaussianBlur stdDeviation='20'/%3E%3C/filter%3E%3Cimage preserveAspectRatio='none' filter='url(%23b)' x='0' y='0' height='100%25' width='100%25' href='data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw=='/%3E%3C/svg%3E")" sizes="(min-width: 874px) 38vw, (min-width: 720px) 44vw, (min-width: 601px) 19vw, 10vw" srcSet="https://media.magloft.app/pdf-import/1144/images/img_13-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=16 16w, https://media.magloft.app/pdf-import/1144/images/img_13-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=32 32w, https://media.magloft.app/pdf-import/1144/images/img_13-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=48 48w, https://media.magloft.app/pdf-import/1144/images/img_13-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=54 54w, https://media.magloft.app/pdf-import/1144/images/img_13-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=64 64w, https://media.magloft.app/pdf-import/1144/images/img_13-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=70 70w, https://media.magloft.app/pdf-import/1144/images/img_13-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=82 82w, https://media.magloft.app/pdf-import/1144/images/img_13-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=96 96w, https://media.magloft.app/pdf-import/1144/images/img_13-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=96 96w, https://media.magloft.app/pdf-import/1144/images/img_13-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=110 110w, https://media.magloft.app/pdf-import/1144/images/img_13-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=128 128w, https://media.magloft.app/pdf-import/1144/images/img_13-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=128 128w, https://media.magloft.app/pdf-import/1144/images/img_13-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=138 138w, https://media.magloft.app/pdf-import/1144/images/img_13-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=192 192w, https://media.magloft.app/pdf-import/1144/images/img_13-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=200 200w, https://media.magloft.app/pdf-import/1144/images/img_13-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=252 252w, https://media.magloft.app/pdf-import/1144/images/img_13-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=256 256w, https://media.magloft.app/pdf-import/1144/images/img_13-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=260 260w, https://media.magloft.app/pdf-import/1144/images/img_13-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=298 298w, https://media.magloft.app/pdf-import/1144/images/img_13-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=378 378w, https://media.magloft.app/pdf-import/1144/images/img_13-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=384 384w, https://media.magloft.app/pdf-import/1144/images/img_13-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=384 384w, https://media.magloft.app/pdf-import/1144/images/img_13-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=520 520w, https://media.magloft.app/pdf-import/1144/images/img_13-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=640 640w, https://media.magloft.app/pdf-import/1144/images/img_13-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=756 756w, https://media.magloft.app/pdf-import/1144/images/img_13-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=828 828w, https://media.magloft.app/pdf-import/1144/images/img_13-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=1080 1080w, https://media.magloft.app/pdf-import/1144/images/img_13-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=1200 1200w, https://media.magloft.app/pdf-import/1144/images/img_13-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=1920 1920w, https://media.magloft.app/pdf-import/1144/images/img_13-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=2048 2048w" src="https://media.magloft.app/pdf-import/1144/images/img_13-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=2048"/></div><div class="_card-body_n1ew6_86"><span class="_card-title_n1ew6_103">CytexOrtho receives FDA greenlight for clinical trials into joint repair technology</span><p class="">Clinical stage medical device company CytexOrtho has announced approval from the US Food and Drug Administration (FDA) for its planned phase 1 clinical trial into orthopaedic joint preservation and repair.</p><div class="_card-date_n1ew6_142">15 November 2024<span class="_category-chip_n1ew6_155" style="background-color:#444444">Approvals</span></div></div><div class="_card-footer_n1ew6_162"><button class="_button_19h3g_1 _text_19h3g_12 _medium_19h3g_38 _secondary_19h3g_22" type="button">Read More</button></div></a><a class="_card_n1ew6_1" href="/articles/survey-from-roche-finds-worryingly-low-understandings-about-hpv"><div class="_card-header_n1ew6_50"><img alt="article-item" loading="lazy" width="86" height="64.5" decoding="async" data-nimg="1" style="color:transparent;width:100%;height:auto;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url("data:image/svg+xml;charset=utf-8,%3Csvg xmlns='http%3A//www.w3.org/2000/svg' viewBox='0 0 86 64.5'%3E%3Cfilter id='b' color-interpolation-filters='sRGB'%3E%3CfeGaussianBlur stdDeviation='20'/%3E%3C/filter%3E%3Cimage preserveAspectRatio='none' filter='url(%23b)' x='0' y='0' height='100%25' width='100%25' href='data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw=='/%3E%3C/svg%3E")" sizes="(min-width: 874px) 38vw, (min-width: 720px) 44vw, (min-width: 601px) 19vw, 10vw" srcSet="https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=16 16w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=32 32w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=48 48w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=54 54w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=64 64w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=70 70w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=82 82w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=96 96w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=96 96w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=110 110w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=128 128w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=128 128w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=138 138w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=192 192w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=200 200w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=252 252w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=256 256w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=260 260w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=298 298w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=378 378w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=384 384w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=384 384w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=520 520w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=640 640w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=756 756w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=828 828w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=1080 1080w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=1200 1200w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=1920 1920w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=2048 2048w" src="https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=2048"/></div><div class="_card-body_n1ew6_86"><span class="_card-title_n1ew6_103">Survey from Roche finds worryingly low understandings about HPV and cervical cancer</span><p class="">Questioning almost 9,000 participants across 12 countries in Latin America and Europe, the research revealed significant knowledge gaps surrounding human papillomavirus (HPV) and highlighted several significant barriers preventing women from screening for it.</p><div class="_card-date_n1ew6_142">11 November 2024<span class="_category-chip_n1ew6_155" style="background-color:#444444">Approvals</span></div></div><div class="_card-footer_n1ew6_162"><button class="_button_19h3g_1 _text_19h3g_12 _medium_19h3g_38 _secondary_19h3g_22" type="button">Read More</button></div></a><a class="_card_n1ew6_1" href="/articles/best-in-class-ai-model-from-bioptimus-integrated-into-proscia-s"><div class="_card-header_n1ew6_50"><img alt="article-item" loading="lazy" width="86" height="64.5" decoding="async" data-nimg="1" style="color:transparent;width:100%;height:auto;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url("data:image/svg+xml;charset=utf-8,%3Csvg xmlns='http%3A//www.w3.org/2000/svg' viewBox='0 0 86 64.5'%3E%3Cfilter id='b' color-interpolation-filters='sRGB'%3E%3CfeGaussianBlur stdDeviation='20'/%3E%3C/filter%3E%3Cimage preserveAspectRatio='none' filter='url(%23b)' x='0' y='0' height='100%25' width='100%25' href='data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw=='/%3E%3C/svg%3E")" sizes="(min-width: 874px) 38vw, (min-width: 720px) 44vw, (min-width: 601px) 19vw, 10vw" srcSet="https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=16 16w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=32 32w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=48 48w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=54 54w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=64 64w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=70 70w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=82 82w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=96 96w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=96 96w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=110 110w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=128 128w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=128 128w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=138 138w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=192 192w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=200 200w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=252 252w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=256 256w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=260 260w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=298 298w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=378 378w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=384 384w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=384 384w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=520 520w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=640 640w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=756 756w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=828 828w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=1080 1080w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=1200 1200w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=1920 1920w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=2048 2048w" src="https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=2048"/></div><div class="_card-body_n1ew6_86"><span class="_card-title_n1ew6_103">Best-in-class AI model from Bioptimus integrated into Proscia’s leading software platform</span><p class="">French start-up Bioptimus has announced that its H-optimus-o biology reference artificial intelligence (AI) foundation model has been wholly integrated into Proscia’s Concentriq Embeddings software platform, with the aim of enabling quicker and more efficient breakthroughs in AI development for therapeutic research.</p><div class="_card-date_n1ew6_142">11 November 2024<span class="_category-chip_n1ew6_155" style="background-color:#444444">Approvals</span></div></div><div class="_card-footer_n1ew6_162"><button class="_button_19h3g_1 _text_19h3g_12 _medium_19h3g_38 _secondary_19h3g_22" type="button">Read More</button></div></a><a class="_card_n1ew6_1" href="/articles/hiv-vaccine-candidate-successfully-optimised-for-industrial-prod"><div class="_card-header_n1ew6_50"><img alt="article-item" loading="lazy" width="86" height="64.5" decoding="async" data-nimg="1" style="color:transparent;width:100%;height:auto;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url("data:image/svg+xml;charset=utf-8,%3Csvg xmlns='http%3A//www.w3.org/2000/svg' viewBox='0 0 86 64.5'%3E%3Cfilter id='b' color-interpolation-filters='sRGB'%3E%3CfeGaussianBlur stdDeviation='20'/%3E%3C/filter%3E%3Cimage preserveAspectRatio='none' filter='url(%23b)' x='0' y='0' height='100%25' width='100%25' href='data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw=='/%3E%3C/svg%3E")" sizes="(min-width: 874px) 38vw, (min-width: 720px) 44vw, (min-width: 601px) 19vw, 10vw" srcSet="https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=16 16w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=32 32w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=48 48w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=54 54w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=64 64w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=70 70w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=82 82w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=96 96w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=96 96w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=110 110w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=128 128w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=128 128w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=138 138w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=192 192w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=200 200w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=252 252w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=256 256w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=260 260w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=298 298w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=378 378w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=384 384w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=384 384w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=520 520w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=640 640w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=756 756w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=828 828w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=1080 1080w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=1200 1200w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=1920 1920w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=2048 2048w" src="https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=2048"/></div><div class="_card-body_n1ew6_86"><span class="_card-title_n1ew6_103">HIV vaccine candidate successfully optimised for industrial production</span><p class="">Sumagen Canada Inc, a biotech company based in both South Korea and Canada has partnered with CDMO Naobios to industrialise Sumagen’s human immunodeficiency virus (HIV)-1 vaccine candidate (SAV0001) at bench scale.</p><div class="_card-date_n1ew6_142">11 November 2024<span class="_category-chip_n1ew6_155" style="background-color:#444444">Approvals</span></div></div><div class="_card-footer_n1ew6_162"><button class="_button_19h3g_1 _text_19h3g_12 _medium_19h3g_38 _secondary_19h3g_22" type="button">Read More</button></div></a><a class="_card_n1ew6_1" href="/articles/aravax-successfully-recruits-for-phase-3-peanut-allergy-treatmen"><div class="_card-header_n1ew6_50"><img alt="article-item" loading="lazy" width="86" height="64.5" decoding="async" data-nimg="1" style="color:transparent;width:100%;height:auto;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url("data:image/svg+xml;charset=utf-8,%3Csvg xmlns='http%3A//www.w3.org/2000/svg' viewBox='0 0 86 64.5'%3E%3Cfilter id='b' color-interpolation-filters='sRGB'%3E%3CfeGaussianBlur stdDeviation='20'/%3E%3C/filter%3E%3Cimage preserveAspectRatio='none' filter='url(%23b)' x='0' y='0' height='100%25' width='100%25' href='data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw=='/%3E%3C/svg%3E")" sizes="(min-width: 874px) 38vw, (min-width: 720px) 44vw, (min-width: 601px) 19vw, 10vw" srcSet="https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=16 16w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=32 32w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=48 48w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=54 54w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=64 64w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=70 70w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=82 82w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=96 96w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=96 96w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=110 110w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=128 128w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=128 128w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=138 138w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=192 192w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=200 200w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=252 252w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=256 256w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=260 260w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=298 298w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=378 378w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=384 384w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=384 384w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=520 520w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=640 640w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=756 756w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=828 828w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=1080 1080w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=1200 1200w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=1920 1920w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=2048 2048w" src="https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=2048"/></div><div class="_card-body_n1ew6_86"><span class="_card-title_n1ew6_103">Aravax successfully recruits for phase 3 peanut allergy treatment study</span><p class="">Clinical-stage biotech company Aravax has announced that it has completed phase 2 recruitment for its precision therapy (pvx108) study, which investigates treatment of peanut allergies.</p><div class="_card-date_n1ew6_142">11 November 2024<span class="_category-chip_n1ew6_155" style="background-color:#444444">General News</span></div></div><div class="_card-footer_n1ew6_162"><button class="_button_19h3g_1 _text_19h3g_12 _medium_19h3g_38 _secondary_19h3g_22" type="button">Read More</button></div></a><a class="_card_n1ew6_1" href="/articles/headlands-research-opens-new-clinical-trials-site-in-el-paso-te"><div class="_card-header_n1ew6_50"><img alt="article-item" loading="lazy" width="86" height="64.5" decoding="async" data-nimg="1" style="color:transparent;width:100%;height:auto;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url("data:image/svg+xml;charset=utf-8,%3Csvg xmlns='http%3A//www.w3.org/2000/svg' viewBox='0 0 86 64.5'%3E%3Cfilter id='b' color-interpolation-filters='sRGB'%3E%3CfeGaussianBlur stdDeviation='20'/%3E%3C/filter%3E%3Cimage preserveAspectRatio='none' filter='url(%23b)' x='0' y='0' height='100%25' width='100%25' href='data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw=='/%3E%3C/svg%3E")" sizes="(min-width: 874px) 38vw, (min-width: 720px) 44vw, (min-width: 601px) 19vw, 10vw" srcSet="https://media.magloft.app/pdf-import/1125/images/img_6-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=16 16w, https://media.magloft.app/pdf-import/1125/images/img_6-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=32 32w, https://media.magloft.app/pdf-import/1125/images/img_6-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=48 48w, https://media.magloft.app/pdf-import/1125/images/img_6-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=54 54w, https://media.magloft.app/pdf-import/1125/images/img_6-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=64 64w, https://media.magloft.app/pdf-import/1125/images/img_6-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=70 70w, https://media.magloft.app/pdf-import/1125/images/img_6-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=82 82w, https://media.magloft.app/pdf-import/1125/images/img_6-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=96 96w, https://media.magloft.app/pdf-import/1125/images/img_6-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=96 96w, https://media.magloft.app/pdf-import/1125/images/img_6-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=110 110w, https://media.magloft.app/pdf-import/1125/images/img_6-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=128 128w, https://media.magloft.app/pdf-import/1125/images/img_6-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=128 128w, https://media.magloft.app/pdf-import/1125/images/img_6-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=138 138w, https://media.magloft.app/pdf-import/1125/images/img_6-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=192 192w, https://media.magloft.app/pdf-import/1125/images/img_6-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=200 200w, https://media.magloft.app/pdf-import/1125/images/img_6-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=252 252w, https://media.magloft.app/pdf-import/1125/images/img_6-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=256 256w, https://media.magloft.app/pdf-import/1125/images/img_6-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=260 260w, https://media.magloft.app/pdf-import/1125/images/img_6-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=298 298w, https://media.magloft.app/pdf-import/1125/images/img_6-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=378 378w, https://media.magloft.app/pdf-import/1125/images/img_6-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=384 384w, https://media.magloft.app/pdf-import/1125/images/img_6-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=384 384w, https://media.magloft.app/pdf-import/1125/images/img_6-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=520 520w, https://media.magloft.app/pdf-import/1125/images/img_6-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=640 640w, https://media.magloft.app/pdf-import/1125/images/img_6-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=756 756w, https://media.magloft.app/pdf-import/1125/images/img_6-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=828 828w, https://media.magloft.app/pdf-import/1125/images/img_6-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=1080 1080w, https://media.magloft.app/pdf-import/1125/images/img_6-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=1200 1200w, https://media.magloft.app/pdf-import/1125/images/img_6-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=1920 1920w, https://media.magloft.app/pdf-import/1125/images/img_6-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=2048 2048w" src="https://media.magloft.app/pdf-import/1125/images/img_6-2.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=2048"/></div><div class="_card-body_n1ew6_86"><span class="_card-title_n1ew6_103">Headlands Research opens new clinical trials site in El Paso, Texas, to serve Hispanic population</span><p class="">Headlands Research, a multinational network of clinical research sites, has launched a new clinical trials site in El Paso, Texas, US.</p><div class="_card-date_n1ew6_142">10 October 2024<span class="_category-chip_n1ew6_155" style="background-color:#444444">Approvals</span></div></div><div class="_card-footer_n1ew6_162"><button class="_button_19h3g_1 _text_19h3g_12 _medium_19h3g_38 _secondary_19h3g_22" type="button">Read More</button></div></a><a class="_card_n1ew6_1" href="/articles/biologic-medicine-dupixent-approved-by-fda-for-copd-patients-in"><div class="_card-header_n1ew6_50"><img alt="article-item" loading="lazy" width="86" height="64.5" decoding="async" data-nimg="1" style="color:transparent;width:100%;height:auto;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url("data:image/svg+xml;charset=utf-8,%3Csvg xmlns='http%3A//www.w3.org/2000/svg' viewBox='0 0 86 64.5'%3E%3Cfilter id='b' color-interpolation-filters='sRGB'%3E%3CfeGaussianBlur stdDeviation='20'/%3E%3C/filter%3E%3Cimage preserveAspectRatio='none' filter='url(%23b)' x='0' y='0' height='100%25' width='100%25' href='data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw=='/%3E%3C/svg%3E")" sizes="(min-width: 874px) 38vw, (min-width: 720px) 44vw, (min-width: 601px) 19vw, 10vw" srcSet="https://media.magloft.app/pdf-import/1125/images/img_8-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=16 16w, https://media.magloft.app/pdf-import/1125/images/img_8-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=32 32w, https://media.magloft.app/pdf-import/1125/images/img_8-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=48 48w, https://media.magloft.app/pdf-import/1125/images/img_8-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=54 54w, https://media.magloft.app/pdf-import/1125/images/img_8-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=64 64w, https://media.magloft.app/pdf-import/1125/images/img_8-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=70 70w, https://media.magloft.app/pdf-import/1125/images/img_8-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=82 82w, https://media.magloft.app/pdf-import/1125/images/img_8-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=96 96w, https://media.magloft.app/pdf-import/1125/images/img_8-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=96 96w, https://media.magloft.app/pdf-import/1125/images/img_8-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=110 110w, https://media.magloft.app/pdf-import/1125/images/img_8-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=128 128w, https://media.magloft.app/pdf-import/1125/images/img_8-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=128 128w, https://media.magloft.app/pdf-import/1125/images/img_8-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=138 138w, https://media.magloft.app/pdf-import/1125/images/img_8-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=192 192w, https://media.magloft.app/pdf-import/1125/images/img_8-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=200 200w, https://media.magloft.app/pdf-import/1125/images/img_8-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=252 252w, https://media.magloft.app/pdf-import/1125/images/img_8-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=256 256w, https://media.magloft.app/pdf-import/1125/images/img_8-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=260 260w, https://media.magloft.app/pdf-import/1125/images/img_8-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=298 298w, https://media.magloft.app/pdf-import/1125/images/img_8-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=378 378w, https://media.magloft.app/pdf-import/1125/images/img_8-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=384 384w, https://media.magloft.app/pdf-import/1125/images/img_8-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=384 384w, https://media.magloft.app/pdf-import/1125/images/img_8-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=520 520w, https://media.magloft.app/pdf-import/1125/images/img_8-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=640 640w, https://media.magloft.app/pdf-import/1125/images/img_8-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=756 756w, https://media.magloft.app/pdf-import/1125/images/img_8-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=828 828w, https://media.magloft.app/pdf-import/1125/images/img_8-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=1080 1080w, https://media.magloft.app/pdf-import/1125/images/img_8-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=1200 1200w, https://media.magloft.app/pdf-import/1125/images/img_8-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=1920 1920w, https://media.magloft.app/pdf-import/1125/images/img_8-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=2048 2048w" src="https://media.magloft.app/pdf-import/1125/images/img_8-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=2048"/></div><div class="_card-body_n1ew6_86"><span class="_card-title_n1ew6_103">Biologic medicine Dupixent approved by FDA for COPD patients in the US</span><p class="">The US Food and Drug Administration has approved Sanofi’s Dupixent as an add-on maintenance treatment for adults with inadequately controlled chronic obstructive pulmonary disease (COPD) and an eosinophilic phenotype.</p><div class="_card-date_n1ew6_142">10 October 2024<span class="_category-chip_n1ew6_155" style="background-color:#444444">Approvals</span></div></div><div class="_card-footer_n1ew6_162"><button class="_button_19h3g_1 _text_19h3g_12 _medium_19h3g_38 _secondary_19h3g_22" type="button">Read More</button></div></a><a class="_card_n1ew6_1" href="/articles/tiziana-life-sciences-awarded-4m-grant-by-nih-to-study-anti-cd3"><div class="_card-header_n1ew6_50"><img alt="article-item" loading="lazy" width="86" height="64.5" decoding="async" data-nimg="1" style="color:transparent;width:100%;height:auto;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url("data:image/svg+xml;charset=utf-8,%3Csvg xmlns='http%3A//www.w3.org/2000/svg' viewBox='0 0 86 64.5'%3E%3Cfilter id='b' color-interpolation-filters='sRGB'%3E%3CfeGaussianBlur stdDeviation='20'/%3E%3C/filter%3E%3Cimage preserveAspectRatio='none' filter='url(%23b)' x='0' y='0' height='100%25' width='100%25' href='data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw=='/%3E%3C/svg%3E")" sizes="(min-width: 874px) 38vw, (min-width: 720px) 44vw, (min-width: 601px) 19vw, 10vw" srcSet="https://media.magloft.app/pdf-import/1125/images/img_7-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=16 16w, https://media.magloft.app/pdf-import/1125/images/img_7-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=32 32w, https://media.magloft.app/pdf-import/1125/images/img_7-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=48 48w, https://media.magloft.app/pdf-import/1125/images/img_7-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=54 54w, https://media.magloft.app/pdf-import/1125/images/img_7-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=64 64w, https://media.magloft.app/pdf-import/1125/images/img_7-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=70 70w, https://media.magloft.app/pdf-import/1125/images/img_7-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=82 82w, https://media.magloft.app/pdf-import/1125/images/img_7-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=96 96w, https://media.magloft.app/pdf-import/1125/images/img_7-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=96 96w, https://media.magloft.app/pdf-import/1125/images/img_7-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=110 110w, https://media.magloft.app/pdf-import/1125/images/img_7-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=128 128w, https://media.magloft.app/pdf-import/1125/images/img_7-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=128 128w, https://media.magloft.app/pdf-import/1125/images/img_7-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=138 138w, https://media.magloft.app/pdf-import/1125/images/img_7-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=192 192w, https://media.magloft.app/pdf-import/1125/images/img_7-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=200 200w, https://media.magloft.app/pdf-import/1125/images/img_7-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=252 252w, https://media.magloft.app/pdf-import/1125/images/img_7-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=256 256w, https://media.magloft.app/pdf-import/1125/images/img_7-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=260 260w, https://media.magloft.app/pdf-import/1125/images/img_7-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=298 298w, https://media.magloft.app/pdf-import/1125/images/img_7-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=378 378w, https://media.magloft.app/pdf-import/1125/images/img_7-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=384 384w, https://media.magloft.app/pdf-import/1125/images/img_7-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=384 384w, https://media.magloft.app/pdf-import/1125/images/img_7-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=520 520w, https://media.magloft.app/pdf-import/1125/images/img_7-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=640 640w, https://media.magloft.app/pdf-import/1125/images/img_7-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=756 756w, https://media.magloft.app/pdf-import/1125/images/img_7-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=828 828w, https://media.magloft.app/pdf-import/1125/images/img_7-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=1080 1080w, https://media.magloft.app/pdf-import/1125/images/img_7-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=1200 1200w, https://media.magloft.app/pdf-import/1125/images/img_7-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=1920 1920w, https://media.magloft.app/pdf-import/1125/images/img_7-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=2048 2048w" src="https://media.magloft.app/pdf-import/1125/images/img_7-1.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=2048"/></div><div class="_card-body_n1ew6_86"><span class="_card-title_n1ew6_103">Tiziana Life Sciences awarded $4m grant by NIH to study anti-CD3 in Alzheimer’s disease</span><p class="">Tiziana Life Sciences, a biotechnology company developing immunomodulation therapies, announced that the National Institutes of Health (NIH),'s National Institute on Aging has awarded a $4m grant to Dr Howard Weiner as principal investigator at Brigham and Women’s Hospital to be the key research site to study nasal anti-cd3 for the treatment of alzheimer’s disease (ad).</p><div class="_card-date_n1ew6_142">10 October 2024<span class="_category-chip_n1ew6_155" style="background-color:#444444">R & D</span></div></div><div class="_card-footer_n1ew6_162"><button class="_button_19h3g_1 _text_19h3g_12 _medium_19h3g_38 _secondary_19h3g_22" type="button">Read More</button></div></a><a class="_card_n1ew6_1" href="/articles/european-commission-approves-astellas-pharma-s-gej-adenocarcinom"><div class="_card-header_n1ew6_50"><img alt="article-item" loading="lazy" width="86" height="64.5" decoding="async" data-nimg="1" style="color:transparent;width:100%;height:auto;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url("data:image/svg+xml;charset=utf-8,%3Csvg xmlns='http%3A//www.w3.org/2000/svg' viewBox='0 0 86 64.5'%3E%3Cfilter id='b' color-interpolation-filters='sRGB'%3E%3CfeGaussianBlur stdDeviation='20'/%3E%3C/filter%3E%3Cimage preserveAspectRatio='none' filter='url(%23b)' x='0' y='0' height='100%25' width='100%25' href='data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw=='/%3E%3C/svg%3E")" sizes="(min-width: 874px) 38vw, (min-width: 720px) 44vw, (min-width: 601px) 19vw, 10vw" srcSet="https://media.magloft.app/pdf-import/1125/images/pages/pg-008.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=16 16w, https://media.magloft.app/pdf-import/1125/images/pages/pg-008.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=32 32w, https://media.magloft.app/pdf-import/1125/images/pages/pg-008.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=48 48w, https://media.magloft.app/pdf-import/1125/images/pages/pg-008.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=54 54w, https://media.magloft.app/pdf-import/1125/images/pages/pg-008.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=64 64w, https://media.magloft.app/pdf-import/1125/images/pages/pg-008.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=70 70w, https://media.magloft.app/pdf-import/1125/images/pages/pg-008.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=82 82w, https://media.magloft.app/pdf-import/1125/images/pages/pg-008.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=96 96w, https://media.magloft.app/pdf-import/1125/images/pages/pg-008.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=96 96w, https://media.magloft.app/pdf-import/1125/images/pages/pg-008.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=110 110w, https://media.magloft.app/pdf-import/1125/images/pages/pg-008.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=128 128w, https://media.magloft.app/pdf-import/1125/images/pages/pg-008.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=128 128w, https://media.magloft.app/pdf-import/1125/images/pages/pg-008.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=138 138w, https://media.magloft.app/pdf-import/1125/images/pages/pg-008.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=192 192w, https://media.magloft.app/pdf-import/1125/images/pages/pg-008.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=200 200w, https://media.magloft.app/pdf-import/1125/images/pages/pg-008.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=252 252w, https://media.magloft.app/pdf-import/1125/images/pages/pg-008.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=256 256w, https://media.magloft.app/pdf-import/1125/images/pages/pg-008.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=260 260w, https://media.magloft.app/pdf-import/1125/images/pages/pg-008.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=298 298w, https://media.magloft.app/pdf-import/1125/images/pages/pg-008.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=378 378w, https://media.magloft.app/pdf-import/1125/images/pages/pg-008.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=384 384w, https://media.magloft.app/pdf-import/1125/images/pages/pg-008.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=384 384w, https://media.magloft.app/pdf-import/1125/images/pages/pg-008.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=520 520w, https://media.magloft.app/pdf-import/1125/images/pages/pg-008.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=640 640w, https://media.magloft.app/pdf-import/1125/images/pages/pg-008.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=756 756w, https://media.magloft.app/pdf-import/1125/images/pages/pg-008.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=828 828w, https://media.magloft.app/pdf-import/1125/images/pages/pg-008.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=1080 1080w, https://media.magloft.app/pdf-import/1125/images/pages/pg-008.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=1200 1200w, https://media.magloft.app/pdf-import/1125/images/pages/pg-008.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=1920 1920w, https://media.magloft.app/pdf-import/1125/images/pages/pg-008.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=2048 2048w" src="https://media.magloft.app/pdf-import/1125/images/pages/pg-008.jpg?optimizer=image&format=webp&aspectRatio=1.33&width=2048"/></div><div class="_card-body_n1ew6_86"><span class="_card-title_n1ew6_103">European Commission approves Astellas Pharma’s GEJ adenocarcinoma treatment</span><p class="">The European Commission (EC) has approved Astellas Pharma’s vyloy (zolbetuximab) in combination with fluoropyrimidine and platinum-containing chemotherapy as a treatment for adult patients with locally advanced unresectable or metastatic human epidermal growth factor receptor 2 (HER2)negative gastric or gastro-oesophageal junction (GEJ) adenocarcinoma whose tumours are claudin (CLDN) 18.2 positive.</p><div class="_card-date_n1ew6_142">10 October 2024<span class="_category-chip_n1ew6_155" style="background-color:#444444">Approvals</span></div></div><div class="_card-footer_n1ew6_162"><button class="_button_19h3g_1 _text_19h3g_12 _medium_19h3g_38 _secondary_19h3g_22" type="button">Read More</button></div></a></div></div></div></div></div></div><script> //create a new element const terms = document.createElement('div'); //set id terms.setAttribute("id","billboard-banner"); //add the new element to html var body = document.querySelector('body'); body.appendChild(terms); document.querySelector("#billboard-banner").innerHTML = "<ins data-revive-zoneid='1573' data-revive-id='9c421b7e485bf2edfee09708a4d06e2e'></ins>"; //insert new element before header //document.body.insertAdjacentElement('afterbegin', terms); const insElement = document.querySelector("#__next"); insElement.before(terms); </script> <script async="" src="//ads.datateam.co.uk/www/delivery/asyncjs.php"></script><div class="_footer_j8nu5_1"><div class="_container_j8nu5_12"><div class="_footer-row_j8nu5_23"><div class="_footer-column_j8nu5_36 _flex-2_j8nu5_117"><div class="_footer-brand_j8nu5_43"><div class=""><img alt="Logo" loading="lazy" width="40" height="40" decoding="async" data-nimg="1" class="_footer-logo_j8nu5_57" style="color:transparent" srcSet="https://media.magloft.app/pwa-664/pwa/logo/8eb186e1-b2cb-4384-a0b7-515f62171b22.png 1x, https://media.magloft.app/pwa-664/pwa/logo/8eb186e1-b2cb-4384-a0b7-515f62171b22.png 2x" src="https://media.magloft.app/pwa-664/pwa/logo/8eb186e1-b2cb-4384-a0b7-515f62171b22.png"/></div><div class="_content_j8nu5_67"><h3>Pharmafocus</h3><p>Pharmaceutical Industry news, analysis and insights</p></div></div><div class="_footer-link-list_j8nu5_121"><div class="_block_j8nu5_129"><a class="_footer-link-item_j8nu5_92" rel="noreferrer" href="mailto:info@pharmafile.com"><div class="_form-email_1lm7t_143 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div><span>info@pharmafile.com</span></a></div><div class="_block_j8nu5_129"><a class="_footer-link-item_j8nu5_92" target="_blank" rel="noreferrer" href="http://www.pharmafile.com"><div class="_status-info_1lm7t_87 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div><span>Pharmafile.com</span></a><a class="_footer-link-item_j8nu5_92" target="_blank" rel="noreferrer" href="https://magazine.pharmafile.com"><div class="_status-info_1lm7t_87 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div><span>Pharmafile Magazine</span></a><a class="_footer-link-item_j8nu5_92" target="_blank" rel="noreferrer" href="http://www.samedanltd.com"><div class="_status-info_1lm7t_87 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div><span>Samedan</span></a></div><a target="_blank" rel="noreferrer" class="_footer-link-item_j8nu5_92" href="https://www.pharmafile.com/privacy-policy"><div class="_status-info_1lm7t_87 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div><span>Privacy Policy</span></a><a target="_blank" rel="noreferrer" class="_footer-link-item_j8nu5_92" href="https://www.pharmafile.com/terms-of-service"><div class="_status-info_1lm7t_87 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div><span>Terms of Service</span></a></div></div><div class="_footer-column_j8nu5_36 _flex-1_j8nu5_39"><div class="_footer-brand_j8nu5_43"><div class="_status-accent_1lm7t_91 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div><div class="_content_j8nu5_67"><h3>Categories</h3><p>Explore our inspiring content by topic</p></div></div><div class="_footer-link-list_j8nu5_121"><a class="_footer-link-item_j8nu5_92" href="/categories/uk-pharma-news"><div class="_nav-arrow-right_1lm7t_175 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div>UK News</a><a class="_footer-link-item_j8nu5_92" href="/categories/general-news"><div class="_nav-arrow-right_1lm7t_175 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div>General News</a><a class="_footer-link-item_j8nu5_92" href="/categories/approvals"><div class="_nav-arrow-right_1lm7t_175 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div>Approvals</a><a class="_footer-link-item_j8nu5_92" href="/categories/research-and-development"><div class="_nav-arrow-right_1lm7t_175 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div>R & D</a><a class="_footer-link-item_j8nu5_92" href="/categories/mergers-acquisitions"><div class="_nav-arrow-right_1lm7t_175 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div>Mergers & Acquisitions</a><a class="_footer-link-item_j8nu5_92" href="/categories/manufacturing-production"><div class="_nav-arrow-right_1lm7t_175 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div>Manufacturing</a><a class="_footer-link-item_j8nu5_92" href="/categories/clinical-trials"><div class="_nav-arrow-right_1lm7t_175 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div>Clinical Trials</a><a class="_footer-link-item_j8nu5_92" href="/categories/industry-insights"><div class="_nav-arrow-right_1lm7t_175 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div>Industry Insights</a><a class="_footer-link-item_j8nu5_92" href="/categories/appointments"><div class="_nav-arrow-right_1lm7t_175 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div>Appointments</a><a class="_footer-link-item_j8nu5_92" href="/categories/insider-interviews"><div class="_nav-arrow-right_1lm7t_175 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div>Interviews</a></div></div><div class="_footer-column_j8nu5_36 _flex-1_j8nu5_39"><div class="_footer-brand_j8nu5_43"><div class="_share-action_1lm7t_463 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div><div class="_content_j8nu5_67"><h3>Social Footprints</h3><p>Follow us on our Social Media Channels</p></div></div><div class="_footer-link-list_j8nu5_121"><a class="_footer-link-item_j8nu5_92" target="_blank" rel="noreferrer" href="https://twitter.com/Pharmafocus"><div class="_share-twitter_1lm7t_487 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div><span class="_footer-text_j8nu5_125">X</span></a><a class="_footer-link-item_j8nu5_92" target="_blank" rel="noreferrer" href="https://www.linkedin.com/company/pharmafile"><div class="_share-linkedin_1lm7t_483 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div><span class="_footer-text_j8nu5_125">linkedin</span></a></div></div></div></div></div></div><div class="Toastify"></div></div><script id="__NEXT_DATA__" type="application/json">{"props":{"pageProps":{"domain":"www.pharmafocus.com","pwa":{"id":664,"publicationId":14882,"pwaOptinId":656,"domain":"www.pharmafocus.com","config":{"access":{"concurrentLimit":null,"restrictAnonymous":null,"disableSignup":null,"disableLogin":null,"disableLoginMessage":null,"disableSearchIndexing":false,"signupUrl":null,"resetPasswordUrl":null,"isUsernameLogin":null,"disableEditProfile":null,"formUrl":null,"customMarginResetPassword":null},"push":{"google":{"serverPublicKey":"BGfKWie38SRvrZs4-bDa1N70rhULMBqX8nAvBZT_2OXsMQi3uRA0CaK4JKPuib9Ega28liCTGhBx0QCY4t1QU7o"}},"tracking":{"facebook":{"appId":null,"pixelId":null},"google":{"measurementId":"G-D8QLP3CKWG"},"gtm":null,"sentry":true},"payment":{"stripe":null,"bypassPayment":null,"mode":"none","external":null,"currency":null},"email":{"readerOptin":false},"firebase":{"projectId":"ipt-magloft","senderId":"497261264876","pairKey":null,"webAppConfig":{"apiKey":"AIzaSyBcHBC8k394YdXp19dZj2Xqe8CXCgThBZs","appId":"1:497261264876:web:98452398b320341bd68ac9","authDomain":"ipt-magloft.firebaseapp.com","databaseURL":null,"locationId":null,"messagingSenderId":"497261264876","projectId":"ipt-magloft","storageBucket":"ipt-magloft.appspot.com"}},"customHtml":{"head":"\u003cscript type=\"text/javascript\" src=\"https://cdn.jsdelivr.net/npm/cookie-bar/cookiebar-latest.min.js?customize=1\u0026always=1\u0026showNoConsent=1\" onload=\"setupCookieBar();\"\u003e\u003c/script\u003e\n\u003cmeta name=\"google-site-verification\" content=\"kuOvGxaH_NjG3aS7GSmbjjV-OjdOAWyiM3gEPGESeHQ\" /\u003e\n\u003cstyle\u003e\n#billboard-banner { text-align:center;}\n#billboard-banner img {width:100%; max-width:970px; height:auto; position:relative; top:70px;}\n.Layout_spacer__qTBD3 {margin-top:70px;}\n\u003c/style\u003e","body":"\u003cscript\u003e\n //create a new element\n const terms = document.createElement('div');\n //set id\n terms.setAttribute(\"id\",\"billboard-banner\");\n //add the new element to html\n var body = document.querySelector('body');\n body.appendChild(terms);\n document.querySelector(\"#billboard-banner\").innerHTML = \"\u003cins data-revive-zoneid='1573' data-revive-id='9c421b7e485bf2edfee09708a4d06e2e'\u003e\u003c/ins\u003e\"; \n //insert new element before header\n//document.body.insertAdjacentElement('afterbegin', terms);\n const insElement = document.querySelector(\"#__next\");\n insElement.before(terms);\n\u003c/script\u003e\n\u003cscript async src=\"//ads.datateam.co.uk/www/delivery/asyncjs.php\"\u003e\u003c/script\u003e"},"account":{"emailEditable":true,"customSubscriptionText":null,"customSubscriptionURL":null,"enableSubscriptionTitle":null},"checkout":null},"design":{"colors":{"backgroundColor":"#FFFFFF","primaryColor":"#1976D2","secondaryColor":"#795FF4","accentColor":"#D76FD6","infoColor":"#41638C","warningColor":"#EF9338","successColor":"#20AD27","dangerColor":"#DF4241","topMenuBackgroundColor":"#EE1C25","topMenuHeadingTitleColor":null,"topMenuHeadingIconColor":null,"topMenuItemTextColor":null,"topMenuItemIconColor":null,"footerMenuBackgroundColor":"#DF1111","footerMenuHeadingTitleColor":null,"footerMenuHeadingTextColor":null,"footerMenuHeadingIconColor":null,"footerMenuItemTextColor":null,"footerMenuItemIconColor":null},"images":{"icon":"https://cdn.magloft.com/pwa-664/pwa/logo/8eb186e1-b2cb-4384-a0b7-515f62171b22.png","feature":"https://cdn.magloft.com/defaults/feature-graphic.jpg","topMenuIcon":"https://cdn.magloft.com/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png","footerMenuIcon":null,"alphaChannelIcon":null},"fonts":{"heading":"trade-gothic-lt-bold","body":"open-sans","ui":"trade-gothic-lt-bold","topMenuTitle":"trade-gothic-lt-bold","topMenuItems":"trade-gothic-lt","topMenuSubtitle":"trade-gothic-lt","footerMenuTitle":null,"footerMenuItems":null},"menuItems":{"collections":{"title":"Magazines"},"articles":{"title":null},"account":{"title":null},"icons":{"enabled":true}},"footerShape":"flat","issueCoverAspectRatio":0.75,"fullscreenCollectionView":"auto","customOverlayToggleView":false,"defaultViewMode":"html","categories":"flat","purchaseList":true,"libraryList":false,"noteList":false,"textToSpeech":false},"layout":{"banners":[{"image":"https://cdn.magloft.com/pwa-1/pwa/banner/aea74608-e04a-4649-b817-c45cc439e28e.png","title":"Start trial now","isHidden":true,"action":{"type":"url","href":"https://www.magloft.com/","target":"_blank","pwaSubscriptionId":null,"pwaSubscription":null,"optinId":null,"optin":null}}],"bottomBanners":[{"image":"https://cdn.magloft.com/pwa-664/pwa/banner/1f66e6ea-9b3a-4477-aba1-18abf54619b8.png","title":null,"isHidden":true,"action":{"type":"url","href":"http://www.samedanltd.com/","target":"_blank","pwaSubscriptionId":null,"pwaSubscription":null,"optinId":null,"optin":null}}],"columnSeparator":"shadow","tabs":[{"route":"","title":"Home","icon":"menu-home","visible":true},{"route":"/articles","title":"Articles","icon":"menu-articles","visible":true},{"route":"/collections","title":"Collections","icon":"menu-issues","visible":true},{"route":"/account","title":"Account","icon":"menu-account","visible":true}],"topMenu":{"showLogo":true,"showSubtitle":false,"showTitle":false,"height":"64px"},"navbar":{"animation":false,"style":"logo-left"},"sections":[{"fullWidth":true,"backgroundColor":"transparent","columnSeparator":"none","columns":[{"size":5,"blocks":[{"type":"banner","image":"https://cdn.magloft.com/pwa-1/pwa/banner/aea74608-e04a-4649-b817-c45cc439e28e.png","isHidden":true,"title":"Start trial now","action":{"type":"url","href":"https://www.magloft.com/","target":"_blank","pwaSubscriptionId":null,"pwaSubscription":null,"optinId":null,"optin":null}}]}]},{"fullWidth":false,"backgroundColor":null,"columnSeparator":"shadow","columns":[{"size":8.5,"blocks":[{"type":"ad","title":"Advertisement","advertisementIds":[],"adCampaignId":892,"condition":null},{"type":"article-list","condition":null,"color":"#F90505","title":"Top Content","variant":"variant-b","articleIds":[262748,254614,260494,260493,260492,258749],"articles":null},{"type":"article-list","condition":null,"color":"#2873B0","title":"Industry Insights","variant":"variant-b","articleIds":[260492,260493,260494,258746,258745,257361],"articles":null},{"type":"article-category","condition":null,"color":"#F90505","title":"UK News","variant":"variant-c","categoryId":43138,"backgroundColor":null,"image":null,"articles":null,"category":null},{"type":"article-category","condition":null,"color":"#2873B0","title":"Global News","variant":"variant-c","categoryId":43140,"backgroundColor":null,"image":null,"articles":null,"category":null},{"type":"ad","title":"Advertisement","advertisementIds":[1319],"adCampaignId":null,"condition":null},{"type":"article-category","condition":null,"color":"#2873B0","title":"European News","variant":"variant-c","categoryId":43139,"backgroundColor":null,"image":null,"articles":null,"category":null},{"type":"guide-install","color":"#444558","title":"How to Install","condition":null}]},{"size":3.5,"blocks":[{"type":"issue-slider","condition":null,"color":"#2873B0","title":"Latest Editions","issueIds":[52826,52799,52483,52217,51921,51722,51533,51435,51240,51075,45938,45939,45940],"thumbnail":{"style":"full-cover","size":"medium"},"borderRadius":null,"zoomOnHover":true,"issues":null},{"type":"ad","title":"Advertisement","advertisementIds":[2210],"adCampaignId":null,"condition":null},{"type":"cta","condition":null,"icon":"symbol-gift","color":"#FB0505","title":"Newsletters","description":"Sign up to our newsletters and digital magazines","action":{"type":"url","href":"https://curwoodcmsltd.formstack.com/forms/samedan","target":"_blank","pwaSubscriptionId":null,"pwaSubscription":null,"optinId":null,"optin":null}},{"type":"ad","title":"Advertisement","advertisementIds":[2067],"adCampaignId":null,"condition":null},{"type":"cta","condition":null,"icon":"symbol-day","color":"#F90505","title":"Pharmafocus Archive","description":"Browse older editions","action":{"type":"url","href":"https://en.calameo.com/subscriptions/6188508","target":"_blank","pwaSubscriptionId":null,"pwaSubscription":null,"optinId":null,"optin":null}},{"type":"ad","title":"Advertisement","advertisementIds":[],"adCampaignId":1044,"condition":null},{"type":"article-category","condition":null,"color":"#F70707","title":"Appointments","variant":"variant-c","categoryId":43146,"backgroundColor":null,"image":null,"articles":null,"category":null},{"type":"ad","title":"Advertisement","advertisementIds":[2249,1320],"adCampaignId":null,"condition":null}]}]},{"fullWidth":true,"backgroundColor":"transparent","columnSeparator":"none","columns":[{"size":5,"blocks":[{"type":"banner","image":"https://cdn.magloft.com/pwa-664/pwa/banner/1f66e6ea-9b3a-4477-aba1-18abf54619b8.png","isHidden":true,"title":"","action":{"type":"url","href":"http://www.samedanltd.com/","target":"_blank","pwaSubscriptionId":null,"pwaSubscription":null,"optinId":null,"optin":null}}]}]}],"columns":[{"size":8.5,"blocks":[{"type":"ad","title":"Advertisement","advertisementIds":[],"adCampaignId":892,"condition":null},{"type":"article-list","condition":null,"color":"#F90505","title":"Top Content","variant":"variant-b","articleIds":[262748,254614,260494,260493,260492,258749],"articles":null},{"type":"article-list","condition":null,"color":"#2873B0","title":"Industry Insights","variant":"variant-b","articleIds":[260492,260493,260494,258746,258745,257361],"articles":null},{"type":"article-category","condition":null,"color":"#F90505","title":"UK News","variant":"variant-c","categoryId":43138,"backgroundColor":null,"image":null,"articles":null,"category":null},{"type":"article-category","condition":null,"color":"#2873B0","title":"Global News","variant":"variant-c","categoryId":43140,"backgroundColor":null,"image":null,"articles":null,"category":null},{"type":"ad","title":"Advertisement","advertisementIds":[1319],"adCampaignId":null,"condition":null},{"type":"article-category","condition":null,"color":"#2873B0","title":"European News","variant":"variant-c","categoryId":43139,"backgroundColor":null,"image":null,"articles":null,"category":null},{"type":"guide-install","color":"#444558","title":"How to Install","condition":null}]},{"size":3.5,"blocks":[{"type":"issue-slider","condition":null,"color":"#2873B0","title":"Latest Editions","issueIds":[52826,52799,52483,52217,51921,51722,51533,51435,51240,51075,45938,45939,45940],"thumbnail":{"style":"full-cover","size":"medium"},"borderRadius":null,"zoomOnHover":true,"issues":null},{"type":"ad","title":"Advertisement","advertisementIds":[2210],"adCampaignId":null,"condition":null},{"type":"cta","condition":null,"icon":"symbol-gift","color":"#FB0505","title":"Newsletters","description":"Sign up to our newsletters and digital magazines","action":{"type":"url","href":"https://curwoodcmsltd.formstack.com/forms/samedan","target":"_blank","pwaSubscriptionId":null,"pwaSubscription":null,"optinId":null,"optin":null}},{"type":"ad","title":"Advertisement","advertisementIds":[2067],"adCampaignId":null,"condition":null},{"type":"cta","condition":null,"icon":"symbol-day","color":"#F90505","title":"Pharmafocus Archive","description":"Browse older editions","action":{"type":"url","href":"https://en.calameo.com/subscriptions/6188508","target":"_blank","pwaSubscriptionId":null,"pwaSubscription":null,"optinId":null,"optin":null}},{"type":"ad","title":"Advertisement","advertisementIds":[],"adCampaignId":1044,"condition":null},{"type":"article-category","condition":null,"color":"#F70707","title":"Appointments","variant":"variant-c","categoryId":43146,"backgroundColor":null,"image":null,"articles":null,"category":null},{"type":"ad","title":"Advertisement","advertisementIds":[2249,1320],"adCampaignId":null,"condition":null}]}]},"seo":{"home":{"title":"Pharmafocus Magazine - covering pharma and biotech since 1986","description":"Reporting on the pharma industry, drug development \u0026 clinical trials, manufacturing, logistics, market access, and patients.\nFrom breaking stories to interviews with senior executives, we look at regulations \u0026 trends to provide useful market intelligence.","image":"https://cdn.magloft.com/pwa-664/seo/image/270800d8-b1de-41b8-86ad-5d262d2b9adf.png","imageAlt":"Pharmafocus Magazine"},"articles":{"title":"Pharmafocus - Articles","description":"Discover the latest articles published by Pharmafocus. Browse and customize the article feed to your preferences and explore latest trends","image":"https://cdn.magloft.com/pwa-664/seo/image/e7a95017-d617-4914-b4b3-09fcfc683f75.png","imageAlt":"Pharmafocus - Articles"},"issues":{"title":"Pharmafocus - Magazine Issues","description":"Explore the latest issues of Pharmafocus Magazine and keep up to date with the latest industry knowledge","image":"https://cdn.magloft.com/pwa-664/seo/image/b1c374f3-b368-4654-bf00-3b5ed81fe6c2.png","imageAlt":"Pharmafocus - Issues"},"account":{"title":"Pharmafocus - Account","description":"Manage your Pharmafocus Reader Account..","image":"https://cdn.magloft.com/pwa-664/seo/image/5ad881b1-a927-4fb1-b331-81963e9a0f84.png","imageAlt":"Reader Account"}},"strings":{"app":{"title":"Pharmafocus","subtitle":"Pharmaceutical Industry news, analysis and insights"},"social":{"facebook":null,"twitter":"https://twitter.com/Pharmafocus","linkedin":"https://www.linkedin.com/company/pharmafile","youtube":null,"instagram":null},"topMenu":{"title":null,"subtitle":null},"footerMenu":{"title":"Pharmafocus","subtitle":null,"description":null,"email":["info@pharmafile.com"],"privacyUrl":"https://www.pharmafile.com/privacy-policy","termsUrl":"https://www.pharmafile.com/terms-of-service","links":[{"name":"Pharmafile.com","url":"http://www.pharmafile.com"},{"name":"Pharmafile Magazine","url":"https://magazine.pharmafile.com"},{"name":"Samedan","url":"http://www.samedanltd.com"}]},"pages":null},"customFonts":[{"identifier":"trade-gothic-lt"},{"identifier":"trade-gothic-lt-bold"}],"phrases":{},"trialEndAt":null,"bypassSubscription":false},"publication":{"id":14882,"title":"Pharmafocus","properties":{"subtitle":null,"appIcon":"images/defaults/app-icon.png","promotionalText":null,"companyName":null,"emailReplyTo":"","privacyUrl":null,"termsUrl":null}},"categories":[{"id":43138,"slug":"uk-pharma-news","title":"UK News","color":"#444444","issueCount":3,"articleCount":79,"categoryGroupIds":[]},{"id":43139,"slug":"general-news","title":"General News","color":"#444444","issueCount":3,"articleCount":78,"categoryGroupIds":[]},{"id":43140,"slug":"approvals","title":"Approvals","color":"#444444","issueCount":3,"articleCount":159,"categoryGroupIds":[]},{"id":43141,"slug":"research-and-development","title":"R \u0026 D","color":"#444444","issueCount":1,"articleCount":174,"categoryGroupIds":[]},{"id":43143,"slug":"mergers-acquisitions","title":"Mergers \u0026 Acquisitions","color":"#444444","issueCount":0,"articleCount":69,"categoryGroupIds":[]},{"id":43144,"slug":"manufacturing-production","title":"Manufacturing","color":"#444444","issueCount":1,"articleCount":31,"categoryGroupIds":[]},{"id":43149,"slug":"clinical-trials","title":"Clinical Trials","color":"#444444","issueCount":2,"articleCount":33,"categoryGroupIds":[]},{"id":43145,"slug":"industry-insights","title":"Industry Insights","color":"#444444","issueCount":1,"articleCount":56,"categoryGroupIds":[]},{"id":43146,"slug":"appointments","title":"Appointments","color":"#444444","issueCount":2,"articleCount":87,"categoryGroupIds":[]},{"id":43147,"slug":"insider-interviews","title":"Interviews","color":"#444444","issueCount":0,"articleCount":9,"categoryGroupIds":[]},{"id":43148,"slug":"features","title":"Features","color":"#444444","issueCount":0,"articleCount":20,"categoryGroupIds":[]},{"id":43142,"slug":"industry-facts","title":"Industry Facts","color":"#444444","issueCount":2,"articleCount":23,"categoryGroupIds":[]}],"pwaSubscriptions":[],"categoryGroups":[],"category":{"id":43140,"slug":"approvals","title":"Approvals","description":"The latest approvals from the global pharmaceutical industry.","color":"#444444","icon":"symbol-bell","image":"https://cdn.magloft.com/pwa-664/category/image/e94277d7-5b82-4bb7-9606-4583408ba608.jpg","position":3,"seoDescription":"Pharmafocus brings you the latest news from the global pharmaceutical industry","categoryGroupIds":[]},"issues":[{"id":52826,"slug":"pharmafocus-november-2024","unlockType":"free","entryArticleSlug":"survey-from-roche-finds-worryingly-low-understandings-about-hpv-a2ec","priceTier":null,"hasPdf":false,"publicationId":14882,"title":"Pharmafocus November 2024","description":"Welcome to Pharmafocus November 2024!","date":1731628800000,"updatedAt":1731925217000,"coverUrl":"https://cdn.magloft.com/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg","source":"typeloft2","aspectRatio":0.706,"categoryIds":[43138,43139,43140,43141,43146,43144,43142],"pwaOptinId":null,"pwaSubscriptionIds":[],"classificationIds":[],"sourceFile":"pwa-664/pdf-import/pdf/2db03f67-b154-4bb4-8f8a-9fd8660f932b.pdf","keywordPhrase":null,"seoDescription":null,"categories":[{"id":43146,"slug":"appointments","title":"Appointments","color":"#444444","issueCount":0,"articleCount":0,"categoryGroupIds":[]},{"id":43140,"slug":"approvals","title":"Approvals","color":"#444444","issueCount":0,"articleCount":0,"categoryGroupIds":[]},{"id":43139,"slug":"general-news","title":"General News","color":"#444444","issueCount":0,"articleCount":0,"categoryGroupIds":[]},{"id":43142,"slug":"industry-facts","title":"Industry Facts","color":"#444444","issueCount":0,"articleCount":0,"categoryGroupIds":[]},{"id":43144,"slug":"manufacturing-production","title":"Manufacturing","color":"#444444","issueCount":0,"articleCount":0,"categoryGroupIds":[]},{"id":43141,"slug":"research-and-development","title":"R \u0026 D","color":"#444444","issueCount":0,"articleCount":0,"categoryGroupIds":[]},{"id":43138,"slug":"uk-pharma-news","title":"UK News","color":"#444444","issueCount":0,"articleCount":0,"categoryGroupIds":[]}],"properties":{"allowPdfDownload":false,"allowRead":true,"pdfOnly":false,"checkoutUrl":null},"screenshots":[]},{"id":52483,"slug":"pharmafocus-october-2024","unlockType":"free","entryArticleSlug":"fda-approves-first-drug-in-50-years-for-treatment-of-schizophren","priceTier":null,"hasPdf":false,"publicationId":14882,"title":"Pharmafocus October 2024","description":"Welcome to the October 2024 edition of Pharmafocus!","date":1728601200000,"updatedAt":1731675001000,"coverUrl":"https://cdn.magloft.com/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg","source":"typeloft2","aspectRatio":0.706,"categoryIds":[43138,43139,43140,43149,43145,43146,43142],"pwaOptinId":null,"pwaSubscriptionIds":[],"classificationIds":[],"sourceFile":"pwa-664/pdf-import/pdf/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.pdf","keywordPhrase":null,"seoDescription":null,"categories":[{"id":43146,"slug":"appointments","title":"Appointments","color":"#444444","issueCount":0,"articleCount":0,"categoryGroupIds":[]},{"id":43140,"slug":"approvals","title":"Approvals","color":"#444444","issueCount":0,"articleCount":0,"categoryGroupIds":[]},{"id":43149,"slug":"clinical-trials","title":"Clinical Trials","color":"#444444","issueCount":0,"articleCount":0,"categoryGroupIds":[]},{"id":43139,"slug":"general-news","title":"General News","color":"#444444","issueCount":0,"articleCount":0,"categoryGroupIds":[]},{"id":43142,"slug":"industry-facts","title":"Industry Facts","color":"#444444","issueCount":0,"articleCount":0,"categoryGroupIds":[]},{"id":43145,"slug":"industry-insights","title":"Industry Insights","color":"#444444","issueCount":0,"articleCount":0,"categoryGroupIds":[]},{"id":43138,"slug":"uk-pharma-news","title":"UK News","color":"#444444","issueCount":0,"articleCount":0,"categoryGroupIds":[]}],"properties":{"allowPdfDownload":true,"allowRead":true,"pdfOnly":false,"checkoutUrl":null},"screenshots":[]},{"id":52217,"slug":"pharmafocus-september-2024","unlockType":"free","entryArticleSlug":"first-nasal-spray-for-treatment-of-anaphylaxis-approved-by-fda","priceTier":null,"hasPdf":false,"publicationId":14882,"title":"Pharmafocus September 2024","description":"Welcome to the September 2024 issue of Pharmafocus! \nThis issue covers the latest news including new FDA approval for primary biliary cholangitis, NICE recommendations for skyrizi (risankizumab), CHMP opinion on Merck’s KEYTRUDA, as well as articles on precision medicine and oral peptides PLUS what to look out for at this year's CPHI in Milan! ","date":1725577200000,"updatedAt":1725970662000,"coverUrl":"https://cdn.magloft.com/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png","source":"typeloft2","aspectRatio":0.706,"categoryIds":[43138,43139,43140,43149],"pwaOptinId":null,"pwaSubscriptionIds":[],"classificationIds":[],"sourceFile":"pwa-664/pdf-import/pdf/7c2665b2-7a4f-486f-ae94-622756ac873a.pdf","keywordPhrase":null,"seoDescription":"September 2024 issue of Pharmafocus! \nIncluding new FDA approval for primary biliary cholangitis, NICE recommendations for skyrizi (risankizumab), CHMP opinion on KEYTRUDA, articles on precision medicine \u0026 oral peptides PLUS a guide to CPHI in Milan! ","categories":[{"id":43140,"slug":"approvals","title":"Approvals","color":"#444444","issueCount":0,"articleCount":0,"categoryGroupIds":[]},{"id":43149,"slug":"clinical-trials","title":"Clinical Trials","color":"#444444","issueCount":0,"articleCount":0,"categoryGroupIds":[]},{"id":43139,"slug":"general-news","title":"General News","color":"#444444","issueCount":0,"articleCount":0,"categoryGroupIds":[]},{"id":43138,"slug":"uk-pharma-news","title":"UK News","color":"#444444","issueCount":0,"articleCount":0,"categoryGroupIds":[]}],"properties":{"allowPdfDownload":true,"allowRead":true,"pdfOnly":false,"checkoutUrl":null},"screenshots":[]}],"articles":[{"id":269386,"slug":"nice-gives-positive-recommendation-for-santen-s-roclanda-e19d","issueId":52826,"categoryIds":[43140],"title":"NICE gives positive recommendation for Santen’s Roclanda","description":"The National Institute for Health and Care Excellence (NICE) has given a positive recommendation for Santen’s Roclanda (netarsudil 0.02% and latanoprost 0.005%) as an option for patients suffering from primary open-angle glaucoma (poag) or ocular hypertension.","image":"https://cdn.magloft.com/pdf-import/1144/images/pages/pg-012.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/269386.jpg?ts=1731583567","date":1731628800000,"unlockType":"free","categories":[{"id":43140,"title":"Approvals","slug":"approvals"}],"pdfPageId":"e9t1LzXt2UO0","visible":true,"showOnToc":true,"bookmark":false,"position":22},{"id":269387,"slug":"chmp-adopts-positive-opinion-for-new-breast-cancer-drug-kisqual-db01","issueId":52826,"categoryIds":[43140],"title":"CHMP adopts positive opinion for new breast cancer drug, Kisquali, from Novartis","description":"Last month, the Committee for Medicinal Products for Human Use (CHMP), which is part of the European Medicines Agency (EMA) announced that it has adopted a positive opinion for Novartis’ Kisquali (ribociclib) as an adjuvant in the treatment of adults with hormone receptor-positive/human epidermal growth factor 2negative (hr+/her2-) early breast cancer (ebc).","image":"https://cdn.magloft.com/pdf-import/1144/images/img_12-1.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/269387.jpg?ts=1731583498","date":1731628800000,"unlockType":"free","categories":[{"id":43140,"title":"Approvals","slug":"approvals"}],"pdfPageId":"e9t1LzXt2UO0","visible":true,"showOnToc":true,"bookmark":false,"position":21},{"id":269388,"slug":"eplontersen-recommended-for-eu-approval-by-chmp-for-treatment-of-aaa6","issueId":52826,"categoryIds":[43140],"title":"Eplontersen recommended for EU approval by CHMP for hereditary transthyretin-mediated amyloidosis","description":"Wainzua (Eplotersen), produced by AstraZeneca and Ionis, has been recommended for approval in the EU by the European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP). The drug will be used as a treatment for hereditary transthyretin-mediated amyloidosis in adult patients who have stage 1 or 2 polyneuropathy (commonly referred to as hattr-pn or attrv-pn).","image":"https://cdn.magloft.com/pdf-import/1144/images/img_13-1.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/269388.jpg?ts=1731583612","date":1731628800000,"unlockType":"free","categories":[{"id":43140,"title":"Approvals","slug":"approvals"}],"pdfPageId":"keimK1fu65iO","visible":true,"showOnToc":true,"bookmark":false,"position":23},{"id":269389,"slug":"cytex-ortho-receives-fda-greenlight-for-clinical-trials-into-join-f46a","issueId":52826,"categoryIds":[43140],"title":"CytexOrtho receives FDA greenlight for clinical trials into joint repair technology","description":"Clinical stage medical device company CytexOrtho has announced approval from the US Food and Drug Administration (FDA) for its planned phase 1 clinical trial into orthopaedic joint preservation and repair.","image":"https://cdn.magloft.com/pdf-import/1144/images/img_13-2.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/269389.jpg?ts=1731583651","date":1731628800000,"unlockType":"free","categories":[{"id":43140,"title":"Approvals","slug":"approvals"}],"pdfPageId":"keimK1fu65iO","visible":true,"showOnToc":true,"bookmark":false,"position":24},{"id":269229,"slug":"survey-from-roche-finds-worryingly-low-understandings-about-hpv","issueId":null,"categoryIds":[43140],"title":"Survey from Roche finds worryingly low understandings about HPV and cervical cancer","description":"Questioning almost 9,000 participants across 12 countries in Latin America and Europe, the research revealed significant knowledge gaps surrounding human papillomavirus (HPV) and highlighted several significant barriers preventing women from screening for it.","image":"https://cdn.magloft.com/pdf-import/1144/images/img_1-1.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/269229.jpg?ts=1731342387","date":1731283200000,"unlockType":"free","categories":[{"id":43140,"title":"Approvals","slug":"approvals"}],"pdfPageId":null,"visible":true,"showOnToc":true,"bookmark":false,"position":1},{"id":269230,"slug":"best-in-class-ai-model-from-bioptimus-integrated-into-proscia-s","issueId":null,"categoryIds":[43140],"title":"Best-in-class AI model from Bioptimus integrated into Proscia’s leading software platform","description":"French start-up Bioptimus has announced that its H-optimus-o biology reference artificial intelligence (AI) foundation model has been wholly integrated into Proscia’s Concentriq Embeddings software platform, with the aim of enabling quicker and more efficient breakthroughs in AI development for therapeutic research.","image":"https://cdn.magloft.com/pdf-import/1144/images/img_2-4.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/269230.jpg?ts=1731342089","date":1731283200000,"unlockType":"free","categories":[{"id":43140,"title":"Approvals","slug":"approvals"}],"pdfPageId":null,"visible":true,"showOnToc":true,"bookmark":false,"position":3},{"id":269239,"slug":"hiv-vaccine-candidate-successfully-optimised-for-industrial-prod","issueId":null,"categoryIds":[43140],"title":"HIV vaccine candidate successfully optimised for industrial production","description":"Sumagen Canada Inc, a biotech company based in both South Korea and Canada has partnered with CDMO Naobios to industrialise Sumagen’s human immunodeficiency virus (HIV)-1 vaccine candidate (SAV0001) at bench scale.","image":"https://cdn.magloft.com/pdf-import/1144/images/img_5-2.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/269239.jpg?ts=1731321762","date":1731283200000,"unlockType":"free","categories":[{"id":43140,"title":"Approvals","slug":"approvals"}],"pdfPageId":"LRiuZ8rPEa0Y","visible":true,"showOnToc":true,"bookmark":false,"position":11},{"id":269243,"slug":"aravax-successfully-recruits-for-phase-3-peanut-allergy-treatmen","issueId":null,"categoryIds":[43139,43140],"title":"Aravax successfully recruits for phase 3 peanut allergy treatment study","description":"Clinical-stage biotech company Aravax has announced that it has completed phase 2 recruitment for its precision therapy (pvx108) study, which investigates treatment of peanut allergies.","image":"https://cdn.magloft.com/pdf-import/1144/images/img_10-1.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/269243.jpg?ts=1731337390","date":1731283200000,"unlockType":"free","categories":[{"id":43140,"title":"Approvals","slug":"approvals"},{"id":43139,"title":"General News","slug":"general-news"}],"pdfPageId":null,"visible":true,"showOnToc":true,"bookmark":false,"position":16},{"id":266509,"slug":"headlands-research-opens-new-clinical-trials-site-in-el-paso-te","issueId":52483,"categoryIds":[43140],"title":"Headlands Research opens new clinical trials site in El Paso, Texas, to serve Hispanic population","description":"Headlands Research, a multinational network of clinical research sites, has launched a new clinical trials site in El Paso, Texas, US.","image":"https://cdn.magloft.com/pdf-import/1125/images/img_6-2.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/266509.jpg?ts=1731321994","date":1728601200000,"unlockType":"free","categories":[{"id":43140,"title":"Approvals","slug":"approvals"}],"pdfPageId":"sMgX71Spwg8I","visible":true,"showOnToc":true,"bookmark":false,"position":12},{"id":266511,"slug":"biologic-medicine-dupixent-approved-by-fda-for-copd-patients-in","issueId":52483,"categoryIds":[43140],"title":"Biologic medicine Dupixent approved by FDA for COPD patients in the US","description":"The US Food and Drug Administration has approved Sanofi’s Dupixent as an add-on maintenance treatment for adults with inadequately controlled chronic obstructive pulmonary disease (COPD) and an eosinophilic phenotype.","image":"https://cdn.magloft.com/pdf-import/1125/images/img_8-1.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/266511.jpg?ts=1728470719","date":1728601200000,"unlockType":"free","categories":[{"id":43140,"title":"Approvals","slug":"approvals"}],"pdfPageId":"Pf855DdtWDPP","visible":true,"showOnToc":true,"bookmark":false,"position":15},{"id":266512,"slug":"tiziana-life-sciences-awarded-4m-grant-by-nih-to-study-anti-cd3","issueId":52483,"categoryIds":[43141,43140],"title":"Tiziana Life Sciences awarded $4m grant by NIH to study anti-CD3 in Alzheimer’s disease","description":"Tiziana Life Sciences, a biotechnology company developing immunomodulation therapies, announced that the National Institutes of Health (NIH),'s National Institute on Aging has awarded a $4m grant to Dr Howard Weiner as principal investigator at Brigham and Women’s Hospital to be the key research site to study nasal anti-cd3 for the treatment of alzheimer’s disease (ad).","image":"https://cdn.magloft.com/pdf-import/1125/images/img_7-1.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/266512.jpg?ts=1728470644","date":1728601200000,"unlockType":"free","categories":[{"id":43140,"title":"Approvals","slug":"approvals"},{"id":43141,"title":"R \u0026 D","slug":"research-and-development"}],"pdfPageId":"QRk6tn4GJotw","visible":true,"showOnToc":true,"bookmark":false,"position":14},{"id":266513,"slug":"european-commission-approves-astellas-pharma-s-gej-adenocarcinom","issueId":52483,"categoryIds":[43140],"title":"European Commission approves Astellas Pharma’s GEJ adenocarcinoma treatment","description":"The European Commission (EC) has approved Astellas Pharma’s vyloy (zolbetuximab) in combination with fluoropyrimidine and platinum-containing chemotherapy as a treatment for adult patients with locally advanced unresectable or metastatic human epidermal growth factor receptor 2 (HER2)negative gastric or gastro-oesophageal junction (GEJ) adenocarcinoma whose tumours are claudin (CLDN) 18.2 positive.","image":"https://cdn.magloft.com/pdf-import/1125/images/pages/pg-008.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/266513.jpg?ts=1728470753","date":1728601200000,"unlockType":"free","categories":[{"id":43140,"title":"Approvals","slug":"approvals"}],"pdfPageId":"Pf855DdtWDPP","visible":true,"showOnToc":true,"bookmark":false,"position":16}]},"__N_SSG":true},"page":"/domains/[domain]/categories/[slug]","query":{"domain":"www.pharmafocus.com","slug":"approvals"},"buildId":"1bBCYhXOG7wsYuaBifvjK","isFallback":false,"gsp":true,"scriptLoader":[]}</script></body></html>